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Mycobacterium tuberculosis (MTB), the agent causing tuberculosis (TB) and latent tuberculosis 
infection (LTBI) imposes a significant public health concern world-wide. The utility and the 
value for simultaneous (parallel) testing with Interferon Gamma Release Assay [IGRA (QFT-
GIT)] and Tuberculin skin test (TST) in detecting MTB infection among applicants for residency 
in Abu Dhabi requires evaluation.  
The objectives of this study are to 1) Provide demographic characteristics of the study sample by 
age categories, and 2) Explore the validity measures of IGRA (QFT-GIT) and TST, and 3) 
Further, to assess the risk of MTB among younger visa applicants compared to older applicants. 
This cross-sectional study analyzes data routinely collected on all adults (18-64 years) seeking a 
residency visa in the Emirate of Abu Dhabi from January – December 2013. Among the 
1,529,389 adults who applied for this visa in 2013, 2,596 individuals presented with an abnormal 
chest X-ray (and who also were HIV negative). 
In our study, nearly two-thirds of males in the sample were from Pakistan and India while almost 
50% of females were from the Philippines. The sensitivity of IGRA (QFT-GIT) test was 72.7%, 
(95% CI: 67.8-77.2) compared to TST sensitivity of 59.1%, (95% CI: 53.8-64.2), (P<0.001). 
The net sensitivity of simultaneous (parallel) testing was 88.8%. The net sensitivity of 
simultaneous (parallel) testing for the younger age group (18-34) years was 91.6% compared to 
83.1% net sensitivity among older individuals (35-64) years. Kappa agreement between IGRA 
(QFT-GIT) and TST was 0.33 (95% CI: 0.29-0.36). The role of chest X-ray in our study was not 




compared to younger individuals (18-34) years, yielding an Odds Ratio (OR) of 0.62 (95% CI 
0.48– 0.81), (P<0.001). 
In conclusion, nearly two-thirds of males in the sample were from Pakistan and India. IGRA 
(QFT-GIT) was more sensitive than TST. The net sensitivity of simultaneous (parallel) testing 
was high. However, Kappa agreement between IGRA (QFT-GIT) and TST in the study was 
considered as only fair concordance.   
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AFB           Acid Fast Bacilli 
 
BCG           Bacillus Calmette-Guerin 
CXR        Chest X-ray, Chest Radiography  
DOH        Department of Health (previously Health Authority – Abu Dhabi, or HAAD) 
ELISA        Enzyme-Linked Immunosorbent Assay  
HCWs        Healthcare Workers 
HIV         Human Immunodeficiency Virus 
IGRA         Interferon-γ release Assay 
LTBI          Latent Tuberculosis Infection 
MDR TB    Multi Drug-Resistant Tuberculosis 
MGIT         Mycobacteria Growth Indicator Tube 
MOTT        Mycobacteria Other Than Tuberculosis 
MTB          Mycobacterium tuberculosis (infection with bacteria can be active or latent) 
NTM          Non-Tuberculous Mycobacteria  
NNS         Number Needed to Screen (to detect one true case of active tuberculosis) 
NLR           Negative Likelihood Ratio 
NPV        Negative Predictive Value 
PLR            Positive Likelihood Ratio 
PPV         Positive Predictive Value 




TB              Tuberculosis (mainly pulmonary tuberculosis) 
TB-PCR     Tuberculosis polymerase chain reaction 
TST            Tuberculin Skin Test  





















Active tuberculosis (TB): A seriously infectious disease caused by a bacterium known as 
Mycobacterium tuberculosis. Mostly affects the lungs but can affect any part of the 
human body.
1, 2, 3 
 
Active tuberculosis case-finding 
Active tuberculosis case-finding: is identical to systematic screening for active TB, 






Close contacts: are individuals who had shared an airspace with a person with pulmonary 
TB for at least 15 hours per week for 71 weeks, or a total of 180 hours during a 
contagious phase, defined as 3 months prior to the collection of the first culture-positive 
sputum or the date of onset of a cough (whichever was longer) until 2 weeks after the 




Enzyme-linked immunosorbent assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA): is a widespread and potent laboratory 





Incidence: is defined as ―the number of new and relapse cases of TB arising in a given 




Latent tuberculosis infection 
Latent tuberculosis infection (LTBI): is defined as a status of persistent immune reaction 
to Mycobacterium tuberculosis without clinical evidence of active TB disease. Infected 











The Number Needed to Screen 
The Number Needed to Screen (or NNS): is the number of individuals that need to 
undergo screening to diagnose one person with active TB.
11, 12 
 
Negative predictive value 
The negative predictive value (NPV) of a test: is the proportion of individuals with a 








The Negative Likelihood Ratio (NLR): is ―the ratio of the probability of negative test in 




Passive tuberculosis case-finding 
Passive tuberculosis case-finding: is a pathway initiated by patient to diagnose TB 
involving: (1) a person recognizes his/ her symptoms of active TB as serious; (2) the 
person having access and seeking care spontaneously at a suitable health facility; (3) a 
clinician correctly identifying that the person fulfills the criteria for suspected TB; and (4) 






Prevalence: is defined as the probability of having the disease also called prior 




Positive predictive value 
The positive predictive value (PPV) of a test: is defined as the proportion of individuals 




Positive Likelihood Ratio 
The Positive Likelihood Ratio (PLR): is ―the ratio of the probability of positive test in 





A risk group: is a group of individuals with a prevalence or incidence of TB that is 





A second screening test: is an examination or other procedures which may be done to 










A screening test, examination or procedure for active tuberculosis 
A screening test, examination or procedure for active tuberculosis: is ―a test, examination 
or other procedure for active tuberculosis distinguishing people with a high likelihood of 
having active TB from people who are highly unlikely to have active TB.













Systematic screening for active TB: is the systematic detection suspected active TB 
disease in individuals within a predetermined target group, utilizing tests, examinations 
or other rapid procedures.
6, 11, 12 
Among those screened positive, the establishment of 
diagnosis needs to be via one or multiple diagnostic tests along with additional clinical 





Tuberculosis (TB): is caused by a bacterium known as Mycobacterium tuberculosis. 
Direct person to person transmission occurs through the exposure to the airborne 
bacterium present in the sputum of the patient. Tuberculosis is present in two major 













Chapter 1 will briefly introduce the concept of Mycobacterium tuberculosis (MTB) infection 
comprised of active (TB) and latent tuberculosis infection (LTBI). This chapter will then briefly 
touch on the status immigrants working in the United Arab Emirates and current health 
challenges. Chapter 1 will then introduce the visa screening standard for residency in Abu Dhabi 
and the role of the Disease Prevention and Screening Centers (DPSCs) in visa screening for 
applicants. A brief description of the required investigations for individuals presenting with 
abnormal chest X-ray will be provided.  Finally, the specific aim and objectives of the study will 
be presented.   
 
Mycobacterium Tuberculosis (MTB) infection: Active (TB) vs. latent tuberculosis 
(LTBI) 
Mycobacterium tuberculosis (MTB) infection is transmitted through the air from one person to 










Tuberculosis (TB) is a serious infectious disease that primarily affects the lungs, but can infect 
any part of the human body.
2
 On the other hand, latent tuberculosis infection (LTBI) is a status 




Fortunately, TB is a curable disease despite the difficult and long treatment requiring a minimum 
of six months of compliance with the treatment regimen.
5
  Worldwide, TB is the ninth leading 
cause of death and had been the leading cause of a single infectious agent, ranking above 
HIV/AIDS for the past five years (from 2012-2016).
6
  In history, TB is the leading cause of 
infectious disease mortality; more than a billion lives have been lost due to TB in the past two 








Worldwide, there were 10.4 million new TB cases which is equivalent to 140 cases per 100000 
population (6.2 million were men, 3.2 million were women and 1 million were children) in the 
year 2016.
6
 There were nearly 1.3 million TB deaths among HIV negative individuals with an 
additional 374000 deaths occurred among HIV-positive individuals in 2016.
6
   
 
The case-fatality ratio (CFR) of an untreated case of active TB is about 50% and the patient will 
transmit the infection to ten to fifteen contacts yearly prior to death or recovery.
7
 According to 
the World Health Organization, too many individuals have undetected TB for too long; late 
detection of TB increases the risk of having poor health outcomes besides the risk of 
transmission of TB to others and consequent distress and poverty that the families of sick 




Recent onset of  active TB can go unnoticed by healthcare providers as an individual might 
present with mild signs and symptoms of the disease such as a cough and fatigue.
7
 Furthermore, 
the majority of pulmonary tuberculosis infections are not evident clinically or not apparent on 
radiological tests.
8
 A study was done recently that showed that the reliance on symptom 
reporting may be inadequate for identifying active TB disease.
9
 According to the World Health 
Organization, systematic screening has the potential to identify TB in individuals who would 
otherwise be missed or would be diagnosed too late.
6
  If systematic screening is properly 
implemented targeting the right risk group, it can reduce suffering from disease and potential 
deaths.
6,10
 However, countries implementing systematic screening need to balance potential 






Though tuberculosis has been declared a global emergency due to its high prevalence, most 
individuals do not develop the disease after infection.
13
Almost one-third of the world‘s 
population has latent TB infection (LTBI).
6, 14
 Individuals with LTBI are asymptomatic and are 
not contagious, yet they signify a future risk of TB disease.
6,14
 Since active TB infection is 
usually the result of endogenous reactivation in countries with a low incidence of TB, detecting 




About one-third of the world populations (i.e. two billion individuals) have been infected with 
the tubercle bacillus, yet the great majorities only have latent tuberculosis infection (LTBI).
13
 In 
general, only 5–10% of individuals having LTBI will develop active pulmonary TB disease and 
become infectious and the greatest risk of progression to active TB disease is during the first two 
years following the exposure.
7, 8
 Nearly, 8–10 million new cases of tuberculosis arise every year 








Unfortunately, in countries with low incidence of the disease, the majority of active TB cases are 
identified among migrants coming from high incidence countries.
16
 There are three main 
mechanisms through which migrants can develop active TB after arrival into a low-incidence 
country: 1) active TB is already present in the migrant upon their arrival; 2) active TB can result 





from the reactivation of the pre-existing LTBI within months or years after the arrival into the 
country in which migrant is seeking residency; and 3) active TB can be attributed to a newly 
acquired infection occurring in the migrants prior to their return to their home countries.
16
 The 
progression of the disease can be triggered by several factors and HIV infection is the highest 
known risk.
7
 In addition, individuals with compromised immune systems have a much higher 
risk of falling ill including those living with malnutrition or diabetes, or those who use tobacco.
6
  
In most low TB incidence countries, TB screening programs are implemented for migrants 
coming from high TB incidence regions.
16
 Soon after their arrival into the host country, migrants 
are screened by chest X-ray for active TB, while LTBI screening is not routinely implemented.
16
  
The primary approach to reducing the incidence of new cases is to interrupt the disease process 
by early identification of individuals with active TB disease and treating them immediately as 
well as by providing prophylactic treatment for those with latent tuberculosis infection 
(LTBI).
6,10,11,12




As international travel for business and pleasure has increased dramatically in recent years, 
countries around the world must be increasingly cautious in detecting the presence of MTB 
infection (active or latent) among individuals seeking residency within their borders. This has 
heightened the need for efficient, affordable tests to detect MTB infection, especially among 




Immigrant’s status in the United Arab Emirates and current health challenges  
The UAE is a country with a high expatriate level; this is especially true in Abu Dhabi where the 




 The median age for 
nationals is 19 years and the median age for expatriates is 31 years (Figure 1.4 and Figure 1.5).
18,
 
19, 20  
 
 
The high level of immigration into Abu Dhabi has contributed to the growing population in the 
Emirate and the rising demand for the screening of adults who apply for resident visas for the 











In the Emirate of Abu Dhabi, respiratory infections are rated as the second most common non-
lifethreatening condition, accounting for 17.2% of inpatient or out-patient consultation with 
physicians across all healthcare facilities and eventually impacting the workforce productivity 
and the quality of life.
18, 19, 20
 The population continues to grow rapidly in Abu Dhabi and the 
introduction of mandatory health insurance granted to all residents of the Emirate ensures access 





Although the incidence rate of TB in UAE is considered low according to the WHO tuberculosis 
report in 2016 (0.79 per 100000 population), the growing number of expatriate workers seeking 
residency in Abu Dhabi is imposing a public health challenge.
6
 A significant number of 
expatriates aged between 20 and 40 years old are employed in construction and are provided 
accommodation in labor camps where the high density of residents in large dormitories can 
contribute to the rapid spread of disease.
18, 19
 Other factors implicated in the transmission of 
MTB include: (1) exposure to an infected person, (2) susceptibility of the person who is 





contacted (immunity status), (3) intensity/duration of exposure (e.g., being a household member 
or a roommate increases risk), (4) high-risk environments (crowded and poorly ventilation 
areas), and (5) infectiousness of the TB strain.
8
  
Health system responses in Abu Dhabi to residency applicants suspected to have 
MTB 
In Abu Dhabi, as elsewhere, the main tasks for the public health sector include a proper 
screening of individuals seeking residency in order to ensure early detection and initiate 
appropriate treatment of active TB cases. These efforts aim at reducing the risk of transmission 
of the disease within the community and thereby reducing future incident cases of TB. This 
requires continuous improvement of the comprehensive TB screening programs to ensure that 
they are able to effectively react in a timely manner as necessary in this evolving healthcare 
sector. The early diagnosis and treatment of TB require a thorough understanding of the health 
system in order to ensure that the developments of comprehensive TB control programs are 
proactive and responsive to the current demands. 
A. Visa screening standard for residency in Abu Dhabi 
In the UAE, three Federal Laws require the health investigation of all applicants for a residence 
visa (No. 27, enacted in 1981 and its Ministerial Decree amendments, No. 7 (2008) and No. 28 
(2010).
20, 21
 The Department of Health (DOH) previously known as the Health Authority of Abu 
Dhabi (HAAD), is the regulatory body of the health sector in the emirate of Abu Dhabi.
21
 
DOH/HAAD set the requirements for visa screening and requires that all individuals seeking 
residence in Abu Dhabi receive a certificate of clearance (a certificate indicating that they are 
free from specific communicable diseases).
21, 22




mandate the guidelines that the healthcare providers of visa screening services are obliged to 
follow.
21, 22
 The routine application of these processes and the procedures as specified by 
DOH/HAAD ensure the consistency of results.
21,22
  
B. Disease Prevention and Screening Centers (DPSCs): Role in visa screening 
Expatriates are screened for communicable diseases prior to acquiring their residency status.
21, 22
 
Visa screening centers in Abu Dhabi are connected electronically with the DOH/HAAD which 




Among all adults applying for a residency visa in Abu Dhabi, a posterior-anterior chest 
radiograph is used for applicants to identify chest abnormalities according to the requirement of 
DOH/HAAD visa screening standard implemented in 2011.
22
 All Chest X-ray Images are 
evaluated by a DOH/HAAD licensed radiologist and documentation is following DOH/HAAD 
reading and reporting format: all images are evaluated either as ‗Normal‘ or as ‗Abnormal‘ (Not 
Pulmonary TB, Old Pulmonary TB, or Suspicion of Active Pulmonary TB).
22
 Lesions may be 
seen anywhere in the lungs and may vary in size, shape, solidity, and in the presence or absence 
of cavitations.
2, 17 




C. Investigations required for individuals with abnormal chest X-ray  
1. AFB sputum microscopy and sputum culture for MTB: The screened individuals are 
required to provide a total of three sputum samples (collected within 8-24 hours interval) 






sputum sample must be collected within three working days from receipt of the 
notification of abnormal chest X-ray evaluation.
22
  
2. Tuberculin Skin Test: TST is performed by the expert nursing staff in DPSCs disease 
control section using the Mantoux method and the result is read 72 hours later.
22
 
Indurations of 15 mm or larger defines a positive TST in adult BCG-vaccinated or non-
vaccinated subjects.
22
 A positive TST result suggests active TB disease or latent TB 
infection. 
3. IGRA: QuantiFERON-TB Gold In-tube test (QFT-GIT) is a whole-blood based enzyme-
linked immunosorbent assay (ELISA) measuring the amount of IFN-γ concentration 
produced in response to three MTB antigens.
10, 17, 23
 Results are measured in IU/ml and 
interpreted according to the manufacturer‘s recommendations as positive, negative, or 
indeterminate.
10, 17, 23
 The test used in the central laboratory in DPSCs is the 




Aims of the study 
This study has three major aims to inform and help guide the work of the immigration screening 
service in Abu Dhabi. The data used in the study was collected by the Emirate of Abu Dhabi 
over a one-year period (2013) on all adult expatriates seeking residency visas. All adult visa 
applicants had a chest X-ray and several blood tests to identify the presence or absence of 
communicable diseases as determined by the Federal Law in the United Arab Emirates.  
In our study, all adults who had a negative HIV test and presented with abnormal chest X-ray 




infection were included as potential TB cases. The final diagnosis of MTB in the study is based 
on the sputum culture test -- ―the gold standard‖ test. Therefore, the study individuals were 
divided according to the final diagnosis result into two main groups: MTB (sputum culture 
positive for MTB) and No MTB (sputum culture negative for MTB). The three aims of the study 
are to:  
1. Provide demographic characteristics of the study sample by age categories. 
2. Explore the sensitivity, specificity, negative predictive value (NPV) and positive 
predictive value (PPV) as well as the negative and positive likelihood ratio of IGRA 
(QFT-GIT) and TST. In addition, the study explores the validity of simultaneous testing 
(parallel) with IGRA (QFT-GIT) and TST, to measure agreement of IGRA and TST 
using a kappa statistic and to explore chest X-ray validity measures. 
3. Explore the risk of MTB among younger age groups (18-34) vs. older (35-64) age 
groups.  
Conclusions 
Chapter 1 introduced the concept of Mycobacterium tuberculosis (MTB) infection which is 
transmitted through the respiratory route from one individual to another and is present in two 
major forms -- active TB disease and latent TB infection (LTBI). In this chapter, the immigration 
status in the UAE in relation to MTB infection revealed that the UAE as a country has a low 
incidence of TB and a very high expatriate level; this is especially true in Abu Dhabi. In 




immigrants coming from high-incidence countries and active TB infection is usually the result of 
reactivation of latent TB infection.  
All visa applicants desiring to enter Abu Dhabi for residency are required to undergo visa 
screening. In Abu Dhabi and as per visa screening requirements for the year 2013, applicants 
with abnormal chest X-ray evaluation had to undergo further diagnostic investigations to confirm 
or to rule out TB disease. Diagnostic investigations included: sputum samples that are sent for 
sputum-smear microscopy (sputum smear AFB test) and sputum culture test as well as giving the 
blood sample for IGRA (QFT-GIT) and doing TST. This chapter then highlighted the three aims 
of the study including the provision of demographic characteristics of the study sample, 
particularly by age, exploring the validity of IGRA (QFT-GIT), TST and chest X-ray and finally, 














Chapter 2 will briefly introduce the current epidemiology of tuberculosis at the global level and 
TB mortality in 2016. This chapter will then review the role of early diagnosis and treatment of 
TB in saving lives and will highlight efforts and possible interventions targeting LTBI. The 
chapter will then introduce the systematic screening of tuberculosis (TB); the main focus will be 
on the objectives and goals of screening, followed by an introduction of the number needed to 
screen (NNS) to detect a case of TB, screening algorithms, screening tests, and diagnostic tests. 
Chapter 2 will then highlight the validity of screening tests (addressing sensitivity and specificity 
of tests) and its limitations in clinical practice, the concept of predictive values, followed by 
likelihood ratios in relation to clinical practice. Finally, guidelines for IGRA and TST in 
immigrant screening will be addressed. 
 
Current epidemiology of tuberculosis (TB) worldwide 
The TB annual incidence rate in 2016 (that is the annual number of incident TB cases relative to 
population size) varied extensively among countries, from under 10 per 100000 population in the 
majority of high-income countries to 150–300 in most of the 30 high TB burden countries 
(Appendix. 3.1- 3.3).
6
 In a few countries such as Democratic People‘s Republic of Korea, 









Tuberculosis cases are unevenly distributed across the world. The majority of the estimated 
number of tuberculosis cases in 2016 occurred in the WHO South-East Asia Region (45%), the 
WHO African Region (25%) and the WHO Western Pacific Region (17%); lesser numbers of 
cases occurred in the Eastern Mediterranean Region (7%), the European Region (3%) and the 
Region of the Americas (3%).
6
  Of all estimated incident cases worldwide, the 30 high TB 




In 2016, six counties (in descending order) -- India, Indonesia, China, Nigeria, Pakistan, and 
South Africa accounted for the largest number (56%) of incident cases globally.
6
 And of these, 
China, India, and Indonesia alone accounted for 45% of global tuberculosis cases in 2016 while 










According to the estimated trends of TB incidence in 2000-2016, the number of incident cases is 
falling slowly as illustrated in the Figures 2.3 and 2.4.
6
 Worldwide, in 2000−2016, the average 
rate of decline in the TB incidence rate was 1.4% per year and was even slightly larger between 
2015 and 2016 as the decline rate reached 1.9%.
6
 To achieve the milestones for reductions in 
cases and deaths as outlined in the End TB Strategy, the decline in the TB incidence rate needs to 















TB mortality in 2016 
There were an estimated1.3 million (range, 1.2 million to 1.4 million) deaths from TB among 
HIV-negative individuals in 2016 and an additional 374000 deaths from TB among HIV-positive 
individuals.
6
 At a global level, among HIV-negative individuals, the absolute number of TB 
deaths has been falling since 2000, from 1.7 million in 2000 to 1.3 million in 2016 (Figure 2.3, 
Figure 2.4).
6
 Between 2000 and 2016, the TB mortality rate (per 100000 population) fell by 37% 
Figure 2. 3: Global trends in the estimated number of incident TB cases and the 
number of TB deaths (in millions), 2000-2016 
Figure 2. 4: Global trends in the estimated TB incidence and mortality rates, 2000-




(Figure 2.4) and by 3.4% between 2015 and 2016.
6
 TB caused more deaths than HIV/AIDS in 











Figure 2. 5: Global trends in the estimated number of deaths caused by TB and 
HIV (in millions), 2000-2016. Shaded areas represent uncertainty intervals 
Figure 2. 6: Estimated numbers of deaths from HIV/AIDS and TB in 2016. Deaths 




The majority of TB deaths (about 82%) occurred among HIV-negative individuals in the WHO 
African Region and the WHO South-East Asia Region in 2016 compared to India which 
accounted for 33% of global TB deaths in 2016 among HIV-negative individuals.
6
  
Worldwide, the number of TB deaths among HIV-negative individuals per 100000 population 
was 17 in 2016, and 22 when TB deaths among HIV-positive individuals were included. A 
considerable variation in the number of TB death among HIV-negative individuals among 
countries was noted in the year 2016 (Figure 2.7).
6
  
The variation in TB deaths among HIV-negative individuals ranged from less than one TB death 
per 100000 population in several high-income countries to more than 40 deaths per100000 
population in a large number of the WHO African Region and in five high TB burden countries 
in Asia, namely Bangladesh, Indonesia, the Democratic People‘s Republic of Korea and Papua 






Figure 2. 7: Estimate TB mortality rates excluding TB deaths among 





At a global level, estimates of TB mortality rates (per 100000 population) for the six WHO 




Early diagnosis and treatment of TB saved lives 
Unfortunately, over one-third of the 9 million individuals who suffer from tuberculosis (TB) 
each year are not diagnosed, and hence are either not notified or fail to initiate or complete 
known, effective treatment.
11
 For those who do initiate treatment a delayed start is attributed to a 
variety of challenges including: difficulties in receiving care resulting in poor health outcomes 
for the affected individuals, disastrous costs for their families and continuous transmission of TB 
to others in their communities.
11
  
Furthermore, often those with the least access to healthcare and therefore treatment for the 
disease are the individuals and communities who are at highest risk of acquiring TB which will 
further complicate the harmful effects of the disease.
11
 Therefore, the call to intensify efforts to 
ensure early identification of an urgent treatment for all individuals with TB is essential due to 






Worldwide, almost 4% of newly diagnosed TB patients and about 20% of patients receiving 
retreatment have multidrug-resistant tuberculosis.
11
 With a standard 6-month course of 4 
antimicrobial drugs that are provided with information and direct supervision, active drug-
susceptible TB disease can be treated and the patient can be cured. 
11
 The support of the patient 




essential to assure adherence to treatment.
11
 Without support and supervision, treatment 




An estimated 53 million lives were saved through proper TB diagnostic procedures and the 
provision of treatment under supervision between 2000 and 2016.
11
 TB treatments averted an 
estimated 44 million deaths among HIV-negative individuals between 2000 and 2016.
6
 An 
additional 9 million deaths among HIV-positive individuals were averted by TB treatment 
supported by ART.
6
 On the other hand, the currently available treatment regimens for drug-
resistant tuberculosis are insufficient in terms of duration, cost, safety, and effectiveness.
11
 
Therefore, improving treatment outcomes requires the development of new safer, affordable and 






Efforts targeting LTBI are needed to lower TB burden worldwide 
Achieving the End TB Strategy targets set for 2030 and 2035 and reducing the burden of disease 
and death caused by TB necessitate the prevention of new infections of Mycobacterium 
tuberculosis and the progression to TB disease (Appendix 3.5).
6, 25
 Therefore, an extraordinary 
acceleration in the rate at which TB incidence drops after 2025 is required in order to reach the 
targets of an 80% reduction in TB incidence by 2030 and a 90% reduction by 2035 compared 
with 2016 (Appendix 3.6).
6




TB infection (LTBI) to active TB disease among the already infected 1.7 billion individuals 




The emphasis on the importance of lowering the progression of LTBI to active disease is evident 
knowing that reactivation of TB is responsible for about 80% of new cases of the disease in some 
low-burden countries.
6
 Therefore, in low-burden countries, there is a clear call for advancing the 
initiation, completion, and reporting of TB preventive treatment for at-risk populations such as 
―patients with silicosis, patients starting anti-tumor necrosis factor (TNF) therapy and patients 




Possible interventions targeting LTBI  
Possible interventions that might result in an improved reduction in the number of cases due to 
reactivation of LTBI include a more effective treatment for LTBI and the development of a 
vaccine capable of preventing reactivation of LTBI in adults. 
6
 There are three main health 
intervention categories available currently for the prevention of TB including: first, the provision 
of LTBI preventive treatment such as isoniazid for 6-9 months; second, the implementation of 
infection control measures to limit the transmission of the causative agent of TB disease and 




A. Contact investigations 
As recommended by World Health Organization, there are two main risk groups requiring 




contacts of confirmed pulmonary TB cases) and individuals living with HIV.
6
 Therefore, the 
coverage of contact investigation and treatment of LTBI among the previously mentioned 
categories is listed among the high priority indicators intended to monitor the implementation of 
the End TB Strategy aiming at a target of more than 90% coverage by 2025.
6, 26
   In 2016, only 
13% of the 1.3 million children estimated to be eligible for treatment had initiated LTBI 
preventive treatment.
6
 In addition, in the year 2016, a total of 60 countries (compared to 57 




B. Infection control 
In the medical literature, it was reported that ―healthcare workers (HCWs) are at higher than 
average risk for infection with Mycobacterium tuberculosis and of developing TB disease‖.
26
 
Therefore, TB infection control measures, including early diagnosis and prompt treatment of 
contagious cases, need to be a priority in healthcare facilities.
26
 In addition, the assessment of 
infection control measures in healthcare facilities periodically is necessary to assure the proper 
adherence to appropriate measures.
6
  
C. BCG vaccination 
In countries with a high TB burden WHO recommends the provision of a single dose of the BCG 
vaccine to all infants shortly after birth as part of childhood immunization program.
6
 On the 
other hand, in countries with low TB burden, the provision of BCG may be restricted to neonates 







BCG vaccination is of value in preventing the dissemination of TB disease including TB 
meningitis and miliary TB, which are in particular associated with high mortality among infants 
and young children.
6
 BCG vaccination coverage in the 30 high TB burden countries varied 
between 58% in Angola and Nigeria and 99% in ―Cambodia, China, Mozambique, the United 
Republic of Tanzania and Zambia‖.
6
 The need for a new vaccine that is more effective than BCG 
is apparent particularly to reduce the risk of infection with Mycobacterium tuberculosis and the 




Systematic screening of tuberculosis (TB): Objectives and goals  
In general, a major objective of screening is to detect active TB as early as possible in order to 
contribute towards two crucial goals: 
 
1. Lowering the risk of poor treatment outcomes, health consequence and the adverse societal 
and economic burdens of TB in individuals diagnosed with the disease. This will eventually 
reduce suffering, the prevalence of TB and ultimately death from TB; 
 
2. Minimizing the risk of TB transmission by shortening the duration of infectiousness among 
those with the disease. This will eventually reduce the incidence of latent TB infection (LTBI) 




Another major objective of screening is to help identify people who are eligible for treatment of 






Moreover, screening can aid in identifying individuals who are at high risk of developing active 
TB and thus may need periodic screening. For instance, individuals with an abnormal chest X-
ray that is compatible with TB (yet not diagnosed with an active disease at the time of screening) 
can get the advantage from periodic screening in the future.
11
 The systematic screening of those 
at high risk for TB is, therefore, a key element of the World Health Organization‘s (WHO) End 




A. The number needed to screen (NNS) to detect a case of TB 
In a specific risk group, the Number Needed to Screen (NNS) to identify one true case of TB is 
―the inverse of the prevalence of detectable TB in that risk group, assuming 100% sensitivity of 
the screening and diagnostic tools being used‖.
11
 For instance, in a given risk group with a very 
low prevalence of detectable TB, a very large number of individuals will need to undergo 
screening in order to find one case of TB, and this will be interpreted as a high NNS.
11
 
Nevertheless, if a given risk group has a high prevalence of TB that can be detected by available 
screening and diagnostic tools, fewer individuals will need to be screened for each case detected, 








One or several screening tests and one or several diagnostic tests combined together are used to 
build an algorithm intended for systematic screening for TB.
 11
 Screening tests must differentiate 





Furthermore, a screening test is intended to identify the subgroup(s) of individuals with the 
highest likelihood of disease and therefore is not intended to be diagnostic.
11
 Individuals with 
positive results on a screening test will then undergo diagnostic tests to confirm or rule out active 
TB based on bacteriological tests.
11
  




A negative diagnostic test might have to be followed up with clinical evaluation (mostly based 
on chest radiography, the presence or absence of symptoms and the evaluation of an individual‘s 
medical history).
11
 A positive diagnostic test result, on the other hand, might have to be re-
confirmed with additional testing and a detailed clinical evaluation if the positive predictive 




Until recently, the primary approach to case-finding to detect TB cases was only through 
individuals presenting themselves to health facilities with symptoms suggestive of the disease, a 
passive approach.
11
 The need for a more active approach to detect TB early was brought about 
by the ongoing case-detection gap, predominantly in certain vulnerable populations, along with 
the persistent delays in diagnosis and continuous transmission of the infection in the 
community.
11
 Therefore it is crucial to consider systematic screening for active TB, particularly 
in selected risk groups.
11
 Given the global impact of the disease, WHO‘s End TB Strategy 
includes systematic screening for active TB in certain high-risk groups within the first 









Therefore, guidelines for screening for active TB and recommendations on prioritizing certain 
risk groups and deciding screening approaches have been published by The World Health 




To improve the early detection of TB two complementary approaches are advised: 
1. Improving the patient-initiated pathway to TB diagnosis; and 




B. Screening algorithms 
Systematic screening for active TB according to the WHO‘s guidelines includes 10 screening 
algorithm options, consisting of a combination of one or two screening tests and a diagnostic test 
(Appendix 3.8).
11
 The development of those algorithms aimed mainly to detect pulmonary TB 
and culture-confirmed pulmonary TB had been established as the gold standard diagnostic tests 
Figure 2. 9: End of TB Strategy includes systematic screening for active TB 





to assess the accuracy of the tests used in the algorithms.
11
 Although the sputum culture is the 
gold standard for diagnostic testing for TB, in these algorithms it is not considered as an initial 
diagnostic test since it demands more resources and requires a much longer waiting time for 
results (2–8 weeks) compared to other tests such as the GeneXpert MTB/RIF test and sputum-




Each of the algorithms has different sensitivity and specificity, and, as a result, different potential 
yields of ―true-positive and true-negative cases and false-positive and false negative‖ TB.
11
 
Moreover, yields differ with the prevalence of TB in the population being screened.
11
 As the 
prevalence of the disease declines, the risk of a false-positive diagnosis increases and this is 
applicable for all algorithms.
11
 For that reason, special attention must be paid to diagnostic 
accuracy, mainly when the prevalence of TB in the screened population is less than 1%.
11
 ―At a 
TB prevalence of 0.5% in the screened population, all of the algorithms have a PPV of less than 
75% (i.e., 25% have a false positive diagnosis) when clinical diagnosis is used for all or some of 
those with a negative result from their initial diagnostic test‖.
11
 The PPV is below 80% for all but 
one algorithm when clinical diagnosis is not considered.
11
 To guarantee high quality of 
diagnostic procedures and clinical assessment special efforts must be taken particularly when TB 




It is important to consider what proportion of false positive and false negative results are 
unacceptable for each given screening situation.
11 
The acceptable sensitivity and specificity of 




especially in groups with a high risk of severe negative effects from missed or delayed diagnosis 
and treatment.
11
 Still, it is essential to utilize an algorithm that has very high sensitivity, even 
though this choice will often lead to lower specificity.
11
 The predictive values of all tests and, 
consequently, the true-positive and false-positive cases and true-negative and false-negative 




When the prevalence is low, it is essential to use an algorithm with a very high specificity so that 
a high proportion of false-positive cases will be avoided.
11
 It might be helpful to evaluate the 
PPV for a number of algorithms which can be much simpler than evaluating accuracy.
11
 That is 
because assessing the accuracy of an algorithm involves the evaluation of the sensitivity which 
requires testing a large number of individuals with the reference standard.
11
 Assessing the PPV, 





The costs and requirements of algorithms vary according to the status of human resources and 
health systems.
11
 The choice of an algorithm for screening and diagnosis depends on several 
factors including: the risk group, the prevalence of TB, the accessibility of resources and the 







C. Screening tests 
Screening immigrants and close contacts for active tuberculosis (TB) and latent tuberculosis 




Some frequently used initial screening tests comprise: 
o Screening for the presence of a cough lasting for longer than 2 weeks; 
o Screening for any symptoms suggestive of TB, such as – 
✓ A cough of any duration (a cough of more than three weeks duration is 
more compatible with TB) 
✓ Hemoptysis (coughing blood) 
✓ Weight loss 
✓ Fever 
✓ Chills 
✓ Chest pain 
✓ Shortness of breath 
✓ Loss of appetite 
✓ Night sweats; 
o Screening with chest radiography.2, 11, 12,17  
 
 
If symptom screening is used initially, this can be followed by chest radiography as a second 
screening step to decrease the number of individuals who need to experience a full diagnostic 
assessment and to improve the pretest probability of the subsequent diagnostic test.
11
 The visa 
screening process in Abu Dhabi follows the same screening methodology described earlier. The 
visa applicants in Abu Dhabi will see the healthcare clinician for history taking and physical 






D. Diagnostic tests 
For individuals who screen positive, each screening algorithm also comprises one of two options 
for diagnostic testing such as sputum-smear microscopy; or a rapid molecular test such as the 
GeneXpert MTB/RIF test.
2, 11, 17
 In the Abu Dhabi visa screening algorithm, the sputum-smear 
microscopy was the test of choice until 2013 prior to the introduction of the GeneXpert 
MTB/RIF test in 2014 as an additional rapid diagnostic test.   
 
The validity of a screening test: sensitivity and specificity in the literature   
The validity of a screening test is defined as the ability of the test to differentiate between those 
who have a disease and who do not.
27
 Validity comprises two components: sensitivity and 
specificity.
27 
The sensitivity of a screening test is defined as the ability of the test to correctly 
identify those who have the disease (i.e., the proportion of diseased individuals correctly 
identified with positive test result).
27
 The specificity of a screening test, on the other hand, is 
defined as the ability of the test to correctly identify those who do not have the disease (i.e., the 




When an individual has a negative result on a screening test, then using a test with a high 
sensitivity will be helpful for ‗ruling out‘ a disease.
28 
A highly sensitive test is most useful to the 
clinician when the test result is negative.
28
 Similarly, a test with a high specificity is helpful for 
‗ruling in‘ a disease if an individual‘s test result is positive.
28
 And a highly specific test is thus 
most useful to the clinician when the test result is positive.
28  
The value of diagnostic tests is their 




generally described by terms such as sensitivity, specificity, positive predictive value and 







In the anticipation of occurrence of a high prevalence tuberculosis setting, it is essential that 
screening would recognize those participants requiring additional investigation.
29 
An easy 
screening strategy should be implemented utilizing tool/s with have high sensitivity.
29 
This 
generally would be followed by a diagnostic test of high specificity to recognize individuals with 
tuberculosis.
29
 However, the performance of the diagnostic test (such as sensitivity and 





A. Limitation of sensitivity and specificity in clinical practice 
Both sensitivity and specificity have a major limitation that they are of no practical use in 
helping the clinician in the estimation of the probability of disease in individual patients.
28
 When 




a clinician sees a patient in the clinic with a positive result for a particular test, the question that 
needs to be answered then would be ‗what is the chance (probability) of disease given the 
positive test?‘ and sadly neither sensitivity nor specificity can be used to answer such a 
question.
28
 This is because both sensitivity and specificity are calculated based on an external 





Given that the patient would have presented to a clinician with a set of signs and symptoms 
rather than a diagnosis, a clinician would not know at the time of visit whether the patient has a 
disease or not and cannot, for that reason, apply these parameters directly to the patient.
28
 As an 
alternative, clinicians need to know the predictive values of tests which are more helpful 




B. Predictive values 
The main purpose of a diagnostic test is to utilize its results to make a diagnosis, thus we need to 
know the probability that the test result will provide the correct diagnosis. Once the result of a 
patient is known, the positive and negative predictive values illustrate a patient‘s probability of 
having a disease.
28
 The positive predictive value (PPV) of a test is defined as the proportion of 
individuals with a positive test result who truly have the disease.
28
 The negative predictive value 
(NPV) of a test, on the other hand, is the proportion of individuals with a negative test result who 
do not actually have the disease.
28
  
The test‘s sensitivity and specificity and the prevalence of the condition for which the test is 
being used determine the predictive value of a test.
28
 Changing prevalence of the disease will 
ultimately result in the variation of both PPV and NPV.
28




apply published predictive values of a test to their own populations, knowing that the prevalence 
of disease in their population is different from that in the published study.
28
 Looking at the 
relationship between the prevalence and the predictive values in (Table 2.2) we can notice that 
the higher prevalence of the disease, the higher the PPV and the more likely a positive result is 





On the other hand, and despite using a test with high sensitivity and specificity, when the 
prevalence of a disease is low, the PPV will be low as well.
28
 In such a condition, a significant 
proportion of individuals who tested positive might not necessarily have the disease.
28
 In clinical 
practice, therefore, the usefulness of a test result for an individual depends on the prevalence of 
the disease in the population being examined and tested.
28
 The diagnostic value of a test will 
improve if the use of the test is limited to those patients who are likely to have the disease in 





Table 2.2: Relationship between predictive values and disease prevalence (a test with a 




C. Likelihood Ratio  
Although the sensitivity and specificity of a test cannot be used to estimate the probability of 
disease in any particular individual, both parameters can be joined together as an index called the 
likelihood ratio (LR).
28, 30
A likelihood ratio in simple words is the percentage of sick individuals 
with a given test result (can be positive or negative) divided by the percentage of well individuals 
with the same result.
31
 Therefore, ―the positive LR is the ratio of the probability of positive test 
in diseased to non-diseased and negative LR is the ratio of the probability of negative test in 
diseased to non-diseased‖.
30
 Positive LR greater than (10) indicates that a positive test is good at 
ruling in a diagnosis.
31
 On the other hand, a negative LR lesser that is lesser than (0.1) implies 




Recommended tests for Tuberculosis (TB) and latent tuberculosis (LTBI) 
TB disease is a leading cause of infectious disease morbidity and mortality worldwide with a lot 
of diagnostic uncertainties.
8
 Both LTBI and TB could be looked at as different moments 
occurring in the context of a continuous pathological process.
32
 LTBI and TB are generally 
distinguished based on the presence (TB) or absence (LTBI) of clinical, laboratory, and chest 
radiography findings.
32
 A comprehensive diagnostic assessment for TB infection must comprise 








A. Radiographic screening  
Radiographic screening can aid in the detection of individuals at high risk of TB.
33 
Radiographic 
findings consistent with former healed pulmonary TB are predictive of subsequent reactivation 
of the disease over nearly 10 years of observation.
33
 The best criterion (strong predictor) for 
identifying individuals at risk of subsequent tuberculosis include the presence of calcified 
nodular densities or fibrosis, and the presence of non-calcified nodular densities in mid and or 
upper lung zones or the presence of typical TB pulmonary infiltrates.
33
 This criterion has a 
sensitivity of 66% and a specificity of 82% for subsequent pulmonary tuberculosis.
33
  
In high-risk populations, chest X-ray screening for TB/LTBI might reveal findings consistent 
with prior and/or active infection.
32
 Imaging, therefore, plays an essential role in risk 
stratification in patients with positive TST or positive IGRA by helping to differentiate between 
latent infection, previous inactive disease, and active disease.
34
 In addition, stratifying for risk of 





B. Sputum for smear and culture  
When individuals are suspected of having active TB, they should be placed in respiratory 
isolation.
34
 Laboratory assessments then should be initiated with obtaining sputum for smear and 
culture.
34
 Performing acid-fast bacilli (AFB) smear microscopy in all patients suspected of 
having pulmonary TB is considered a strong recommendation based on moderate-quality 
evidence.
8 




intervals, if possible in the early morning hours.
34
 The detection of acid-fast-bacilli (AFB) on 
a sputum smear often indicates TB disease.
2, 17
 
Though the acid-fast-bacilli microscopy is easy and quick, it cannot confirm a diagnosis of TB 
since some acid-fast-bacilli are not M. tuberculosis.
2, 17
 Therefore, a culture is done on all initial 
samples to confirm the diagnosis.
2, 17
 The gold standard for the diagnosis of TB is achieved by 
culturing tuberculosis bacteria from a specimen taken from the patient.
32
 A positive culture 
for Mycobacterium tuberculosis confirms the diagnosis of TB disease.
2, 17
 Unfortunately, the 
diagnosis usually takes a long time owing to the slow-growth of this aerobic, non-motile 
bacterium.
32




Both liquid and solid mycobacterial cultures were suggested by guideline taskforces (including: 
the Official American Thoracic Society, Infectious Diseases Society of America and the Centers 
for Diseases Control and Prevention) to be performed for every specimen obtained from an 
individual with suspected TB disease considered as a conditional recommendation based on low-
quality evidence.
8 
Both liquid and solid mycobacterial cultures are used for all the specimens in 




C. TST and IGRA  
The Tuberculin Skin Test (TST) and Interferon Gamma Release Assay (IGRA/QFT-GIT) are 
both indirect tests in that they indicate a cellular immune response to a recent or to a remote 
sensitization with mycobacterial antigens.
35
 These tests cannot differentiate between individuals 
with active TB, LTBI (dormant infection) or even old TB.
35




that infection with TB has taken place is a positive TST or IGRA result, and those asymptomatic 




MTB infection can stimulate a vigorous adaptive cell-mediated immune response that has been 
utilized to discover MTB infection, particularly LTBI.
36 
Currently, two approaches exist to verify 
the adaptive immunity, the tuberculin skin test (TST) and the gamma interferon-γrelease assay 
(IGRA).
36
 The TST measures delayed-type hypersensitivity reactions to a basic combination of 




IGRA test, on the other hand, is based on the measurement of IFN-γ secreted from T cells 
previously exposed to MTB when stimulated in vitro with the MTB-specific antigens such as 
ESAT-6 and CFP-10.
36
 Both ESAT-6 and CFP-10 antigens are encoded by RD1, a genomic 
region present in Mycobacterium tuberculosis yet lacking in all Mycobacterium bovis, BCG 
vaccine strains and most of the NTM.
36, 37
  
The tuberculin skin test (TST) had been used to detect LTBI for about a century; however, the 
TST has known limitations.
38
 TST has a non-specific reactivity in individuals vaccinated with 
BCG and in those with non-tuberculous mycobacteria (NTM).
38
 The development of the 
interferon-γ released by sensitized T cells after stimulation with M. tuberculosis antigens came as 
a result of the advances in molecular biology.
38
  
The interferon-γ tests are more specific than the TST as they use antigens that are not shared by 






IGRAs have higher specificity and sensitivity than the TST.
38
   In addition, IGRAs is more useful 
in close contacts in low-incidence settings as they have a higher predictive value for LTBI 




Guidelines for IGRA and TST in screening 
Since 2005, the use of IGRAs has increased considerably in low-incidence countries.
35 
Various 
studies, meta-analyses, and systematic reviews have been completed to evaluate the role of these 
tests in the diagnosis of latent and active TB.
35
 In general, the use of IGRAs is increasingly 
recommended, however, the majority of current guidelines do not use objective, transparent 
techniques to grade evidence and recommendations, moreover they do not reveal conflicts of 
interests.
35
 There is a considerable variety in the recommendations on IGRAs, and across all the 
guidelines, four main approaches are followed mostly:  
• Two-step approach of TST initially, followed by IGRA 
 • IGRA only  
• TST and IGRA together  
• Either TST or IGRA.
35
  
The high specificity of IGRAs is considered as their most obvious strength since they allow the 
clinician to distinguish between a sensitization caused by BCG vaccination or non-tuberculous 
mycobacterial exposure and contact with an active TB case.
35
 Recent cohort studies suggested 
that IGRAs, similar to the TST, have only modest predictive ability.
35




countries, only 1–3% of IGRA-positive contacts develop active TB over 2 years of follow-up.
35
 
This indicates that interferon-γ alone is perhaps inadequate as a biomarker for disease 
progression, particularly if only measured at baseline.
35
 A more helpful approach may, therefore, 
include a combination of TST/ IGRA and risk factor information.
35
  
Immigrant screening is often a key component of TB control in low-incidence countries as the 
majority of the TB cases occur among recent immigrants and foreign-born individuals.
35
 Most of 
guidelines that have recommendations are from countries with low-incidence (Table 2.3) and 









However, other guidelines also include recommendations for immigrants who are expected to 
develop the active disease (e.g., children or individuals with underlying clinical diseases that 




IGRAs are incorporated in all the guidelines that make recommendations for screening of 
immigrants.
35
 TST followed by an IGRA if positive is the most commonly used algorithm in 
―(UK (for children 5–15 years of age), Italy, Switzerland, Spain, the Netherlands, Norway, 
Ireland, France, Slovakia and Bulgaria)‖.
35
 The goal from this algorithm is to increase specificity 
due to the extensive use of BCG vaccination in TB endemic countries.
35
  
There several advantages of IGRAs over TSTs:  
o A second visit for reading of the test is no longer required; 
o Boosting due to repetitive testing is avoided;  
o Have greater specificity for latent TB infection;  
o Biases are less occurring compared to measuring the size of skin reactions.39 
 
Conclusions  
TB annual incidence rate in 2016 varied among countries, from under 10 per 100000 population 
to 150–300 per 100000 population. Most TB cases occurred in the WHO South-East Asia 
Region and countries including: India, Indonesia, China, Nigeria, Pakistan, and South Africa had 
accounted for the largest number of incident cases globally in 2016. Fortunately, the number of 
incident cases is falling slowly when looking at the trend from the year 2000 till 2016 and this 




estimated 1.3 million deaths occurred from TB among HIV-negative individuals. Fortunately, an 
estimated 44 million deaths among HIV-negative individuals between 2000 and 2016 were 
averted by TB treatment.  
The prevention of new infections of Mycobacterium tuberculosis and the progression to TB 
disease are essential steps in order to reduce the burden of disease and deaths caused by TB and 
eventually to achieve the End TB Strategy targets set for 2030 and 2035. Coverage of contact 
investigation and treatment of LTBI among children below 5 years old is listed among the high 
priority indicators intended to monitor the implementation of the End TB Strategy. 
A screening test is intended to identify the subgroup of individuals with the highest likelihood of 
disease aiming at minimizing the risk of TB transmission and lowering the risk of poor treatment 
outcomes.  Screening algorithm options are available as per WHO guidelines. Individuals with 
positive results on a screening test need to undergo diagnostic tests to confirm or rule out active 
TB based on bacteriological tests. Both sensitivity and specificity depend on a gold standard test 
and, therefore, the predictive values are more useful and informative for clinicians. However, the 
predictive values of tests are influenced by the prevalence of the disease. A higher prevalence of 
the disease will, therefore, give a higher positive predictive value and a positive diagnostic test 
will most likely indicate the presence of disease. A comprehensive assessment of MTB infection 
includes medical history, physical examination, chest X-ray, TST, IGRA, microbiologic smears, 










The presentation of the study methodology will be initiated by research questions and hypotheses 
of the study. A TB conceptual framework will be explained briefly followed by study design and 
description of the study population. This will be followed by the data collection process and the 
tests procedures used in visa screening followed by data management and interpretation. The 
chapter will then touch on the study variables and statistical analysis methods used in the study. 
Finally, data limitations, ethical considerations, and protection of human rights and IRB approval 
will be addressed.   
Hypotheses of the study 
The evidence in support of the use of IGRAs in screening high-risk groups, such as healthcare 
workers, immigrants from high-incidence countries, and close contacts is provided by the 
available studies on cost-effectiveness of TB screening.
38
   In addition, IGRA has been widely 
used to diagnose MTB infection under national guidelines in several developed countries, such 
as the USA, UK, and Japan given its higher sensitivity and specificity for detecting MTB 
infection compared with TST.
35, 36
   Therefore we assume that IGRA is more sensitive than TST 
in detecting MTB among adults during the visa screening process. 
In Poland, a total of 126 adult patients with clinically active TB were enrolled in a study that 
assessed sensitivity, specificity, positive predicted value (PPV), negative predicted value (NPV), 
and analytic accuracy of TST and IGRA among those diagnosed as culture-positive and culture-
negative TB patients.
40




decreased significantly with the age of the patients‖.
40
 Therefore we assumed that IGRA and 
TST sensitivity will reduce as the applicants are older.  
To determine the pooled sensitivity and specificity values for TST and IGRA (QFT-GIT), 
Keyser and colleagues conducted a random effects model meta-analysis that was performed 
using articles in English published between January 2010 and July 2012 in which TST and IGRA 
were performed simultaneously in individuals with and without active tuberculosis infection.
15
 In 
this meta-analysis, QFT-GIT appeared to be more sensitive than TST [75% (95% CI: 61-86) 
versus 64% (95% CI: 48-78)] but similarly specific [71% (95% CI: 62-86) versus 70% (95% CI: 
57-81)].
15
 According to the meta-analysis, IGRA was more accurate in detecting TB infection 
than TST.
15
 Therefore, in our study, we assumed that simultaneous testing (parallel) with IGRA 
(QFT-GIT) and TST will improve the net sensitivity for detecting MTB among adults during the 
visa screening process. 
Chest radiography has good sensitivity yet poor specificity when utilized for the diagnosis of 
pulmonary TB.
32
   In a study done in Kenya assessing the performance of chest X-ray in all 
suspects of tuberculosis (using the sputum culture as the gold standard test), the sensitivity/ 
specificity/ PPV/ NPV of the score ‗any pathology‘ were 92% (95% CI: 90–94), 63% (95% CI: 
58–67), 76% (95% CI: 73–79) and 86 (95% CI: 82–90), respectively.
41
 Therefore we assume that 
chest X-ray has a good sensitivity in detecting TB among adults during the screening for visa 
purposes. 
It was noticed through our clinical practice in visa screening and TB management that the 




assumed that younger visa applicant carries a higher risk of TB compared to older visa 
applicants. 
TB conceptual framework 
Tuberculosis can be clinically suspected in patients with a variety of risk factors.
34
   Therefore, 
any individual at increased risk of the disease is eligible for tuberculosis testing in order to 
recognize and treat those with LTBI, prevent the development of active TB, and prevent further 
spread of the disease.
34
 Two categories are recognized as risk factors for TB including: those that 






Approximately 10 individuals per year will be infected and two new cases of TB will result upon 
contact with an untreated sputum positive patient (Figure 3.1).
42
 Close contacts such as 
household members and healthcare workers are at a higher risk of infection with Mycobacterium 










Individuals at increased risk of exposure are immigrants from endemic regions, individuals with 
a low-income and limited access to health care, intravenous drug users, those who live or work in 
high-risk residential centers such as nursing homes and correctional facilities, and healthcare 
workers.
34
 On the other hand, risk factors associated with a higher risk of progression to active 
TB include: children younger than 4 years, intravenous drug users, recent tuberculosis infection, 





Diabetes is considered as a factor that increases the risk of active TB disease.
42 
In low- and 
middle-income countries almost 70% of individuals are affected by diabetes and the rates are 





Similarly, alcohol had been shown as a strong risk factor for TB disease due to the alteration in 




The situation is even worse when addressing smoking as a risk factor for TB infection and 
disease as it is considered an additional risk of death in individuals diagnosed with active TB 
(Figure 3.1).
42
 Susceptibility to pulmonary tuberculosis in smokers is increased as the clearance 
of mucosal secretion is impaired and the phagocytic ability of alveolar macrophages is reduced 
due to the nicotine in the cigarettes (Figure 3.1).
42
 Therefore it is crucial to consider systematic 







Figure 3.2 highlights possible causes of patient safety challenges in TB resulting in delayed 
diagnosis and management. Attaining desired health outcomes in patient management aspects in 
TB while considering multiple inputs were highlighted. Patients‘ geographical location, culture, 
and income along with scarce resources contribute to the ongoing TB challenges.




Study design and study population 
Design: 
This is a cross-sectional study that analyzed data routinely collected by DOH/HAAD on adults 
(18-64) years seeking a residency visa (new or renewal) in the Emirate of Abu Dhabi from 
January – December 2013.  






Data came from eleven approved visa screening centers in Abu Dhabi, namely: Abu Dhabi 
Disease Prevention and Screening Center (DPSC) which is the largest screening center in the 
Emirate of Abu Dhabi, Mussafah (DPSC), Al Ain (DPSC), Madinat Zayed (DPSC), Gaiathy 
(DPSC), Silla (DPSC), Delma (DPSC), Al Mirfa (DPSC), Shahama (DPSC), Etihad Airways 
(DPSC) and Sweihan (DPSC).  
Inclusion criteria: 
Inclusion criteria included: abnormal chest X-ray observation by radiologist, adults 18 to 64 
years, HIV negative and negative for pregnancy (in females). 
Exclusion criteria: 
Exclusion criteria included: syphilis (3 adults were excluded), age older than 64 years (20 adults 
were excluded), indeterminate result for QFT-GIT (9 adults were excluded), cases from 
screening centers other than DPSCs (296 adults screened in Mubadala were excluded) and the 
growth of Mycobacterium Other than Tuberculosis (MOTT) in sputum culture (281 adults were 







All visa applicants desiring to enter Abu Dhabi for residency purposes (such working, residence 
or study) are required to undergo visa screening.
22 
Applicants, therefore, should either have entry 
permit (for new visa applicants) or a valid residence visa (renewal; for applicants wishing to 




All healthcare providers of visa screening services such as Abu Dhabi Disease Prevention and 
Screening Center (DPSC) must comply with the DOH/HAAD visa screening standards.
22
 The 
process of visa screening is initiated by obtaining a prior consent from applicants applying for 
residency including the consent for testing for HIV, TB, pregnancy, and consent for treatment 
and follow-up.
22
 Applicants are then educated by the healthcare providers in the screening 
centers about the screening tests in a simple language (a language bank is available in DPSCs) 
while maintaining a culturally appropriate approach.
22
 The healthcare provider then reports and 
submit electronically complete and accurate data for all individual screening observations, in 





compliance with the DOH/HAAD Reporting of Health Statistics Policy to DOH/HAAD via the 
visa screening reporting system within a specified format and timeframe.
22
 Reported data must 
comprise all clinical findings (including physician‘s history and physical examinations), 





As determined by the Federal Law in UAE, visa screening tests are classified into occupational 
categories: (A): white collar, construction, and housewives, (Bi/Bii): maids and drivers/food 
handlers and hygienic staff.
22
 Therefore, approved screening providers must comply with the 





A. Tuberculin Skin Test (TST)  
Trained TB-nurses in Disease Prevention and Screening Centers in Abu Dhabi performed this 
test as an intradermal injection at a recommended dose of 0.1 ml tuberculin solution (5 tuberculin 





the test was done properly then, at the needle site, a distinct pale bump will rise and will 




 If a drop of blood appeared following 
the administration of the tuberculin test then the site shall be touched lightly to remove the blood 
while avoiding squeezing out the test material. The individual who received the TST must return 
within 2 or 3 days to have a trained nurse looking for a reaction on the lower part of the arm 








The trained TB-nurse then looks for an elevated, firm area or swelling, over the injection site and 




 Positive TST indicates that the individual‘s body 
was infected with TB bacteria and that further testing are required to determine if the individual 




 On the other hand, a negative TST means that the 




 Induration of ≥ 15 mm was considered a positive test in screening for residency.
22 
B. Interferon-γ release assay (IGRA) 
The QuantiFERON-TB Gold In-Tube test (QFT-GIT) uses three special blood collection tubes to 




 Initially, whole blood (1 ml) is collected into each of the three 
tubes.  One tube contains test antigens and the other two complementary tubes serve as negative 





The blood in the tubes shall be kept at 37C shortly after extraction and within 16 hours of 




 After the incubation period, tubes 





 Results are then generated by The QuantiFERON-TB Gold In-Tube test IT analysis 
software (version 2.17 or later).
24
 For the diagnosing of infection with Mycobacterium 
tuberculosis, IGRA should be used as an adjunct test to aid in the diagnosis.
43
 A positive IGRA 
test result implies that MTB infection is likely; a negative result, on the other hand, suggests that 
infection is not likely. In addition, an indeterminate result signifies an uncertainty regarding the 







C. Sputum collection for AFB smears and cultures 
Sputum is collected in a negative pressure sputum collection room under the supervision of a 
nurse or physician.
44,45,46 
The visa applicant is educated about the process of sputum collection 
that he/she need to follow in order to produce the best specimen.
44, 45, 46
 The applicant is advised 
to deeply inhale air 2 to three times and then to breathe out hard each time.
44, 45, 46
 The applicant 





A sputum specimen should have a volume of 3-5 ml in order to be considered satisfactory 
sample.
44, 45, 46
 Disinfection of the collection room is done by UV lights for 15 minutes prior to 
and after the collection of the specimen from an applicant and in between patients.
44, 45, 46
 A strict 
daily disinfection procedure emphasized and is followed by the laboratory personnel in the 
central laboratory to assure the proper handling of the equipment and the contagious 
specimens.
44, 45, 46
 Three sputum samples are collected from each applicant presenting with 
abnormal chest X-ray evaluation by a radiologist in 8-24 hours interval for investigation under 
microscopy and for culture.
44, 45, 46
 Upon receipt of the sample, the process is initiated shortly on 
the same day of collection and is stored at 2-8 C if the processing cannot be initiated 
immediately.
44, 45, 46
 The biological safety cabinets are always utilized for smear preparation 
procedures while using the proper personal protective equipment.
44, 45, 46
 This is followed by the 
Ziehl-Neelsen staining procedure to examine the acid-fast bacilli in the smear by the binocular 
light microscopy.
44, 45, 46





 The mycobacteria growth indicator tube (MGIT) is utilized to foster growth of the bacteria as it 
is made of liquid broth medium known to yield a faster growth and recovery of the 
mycobacteria.
44, 45, 46
 The labeled MGIT tube is labeled with applicant name, lab number, 
screening application number and date of inoculation prior to incubation in the MGIT machine.
44, 
45, 46
 In addition, the processed specimen is further inoculated on LJ media and incubated as a 
backup of the main MGIT liquid medium.
44, 45, 46
 A positive growth is detected by a signal 
produced by the instrument as a green light showing the exact location of the positive tube in the 
drawer of the machine.
44, 45, 46





Data management and interpretation 
The data was received as password protected multiple excel sheets. Those sheets were eventually 
merged into one excel sheet after the removal of subjects with incomplete test results and the 
removal of subjects who had normal chest X-rays. The data sheet contained initially 68 variables 
and 3205 observations. Unrelated variables (of which there were 42) were eliminated and 26 
variables (and 3202 observations) were selected to establish the data set for analysis.  
Age was not provided in the data set and therefore dates were formatted in order to generate an 
age variable utilizing the date when chest X-ray was first performed during the visa screening. 
Four age categories were created initially: (18-34) years, (35-51) years and (52-64) years and 
(65-85) years. The (65-85) year category contained only 20 observations and those are not to be 
included in the sample as the maximum age will be 64 years and therefore those 20 observations 




(52-64) years. The older two age categories were combined to create the final two age categories: 
younger adults (18-34) and older adults (35-64) years. 
Other variables were labeled as appropriately and categories were created to generate, recode and 
label commands (for nationality, applicant category, and visa type, IGRA value category, AFB 
smear value and chest X-ray categories). Similar to the age categories, three TST categories were 
created initially: (0-9) mm, (10-14) mm and (15-40) mm.  TST observation results were also 
reclassified into two groups: TST (0-14) mm was defined as negative and TST (15-40) mm was 
considered positive in the study. Nationality was initially explored per country and then due to 
inadequate cell numbers, it was categorized using WHO classification of countries.
6 
To provide 
adequate cell sizes, those variables again were collapsed to three-category variable (SEAR, 
AFR/EMR, and WPR/EUR/AMR).   
Chest X-ray evaluations by radiologists were also collapsed into two groups as the numbers in 
the cells were not sufficient for analysis. Therefore, chest X-ray with three levels of suspicion of 
active TB (low, medium and high suspicion) merged together in one group (named: Suspicion of 
TB) and the other two groups were merged together (named: Abnormal Not/Old TB). Similarly, 
the applicant employment category group was collapsed to two categories where Bi (domestic 
helpers) group and Bii (food handlers and hygienic staff) group were merged together due to 
inadequate numbers in the cells. The screening centers were eventually grouped into two main 
categories due to limited numbers and the reference group was changed to the combined DPSCs 




Cases of MTB were extracted from the sample of those with abnormal chest X-ray and identified 
based on the positive result of the sputum culture ―gold standard‖ test. Then a ‗control group‘ 
was generated defined as those with a negative sputum culture test. Therefore, based on the 
sputum test results, two data sets were created where controls included those with sputum test 
negative (MTB=0) and cases were defined as sputum culture test positive (MTB=1) and the final 
dataset were merged together to form the final data set for the study sample analysis. Thus, the 
final analytic sample included both cases and controls in one data sheet for analysis.   
 
Study variables 
A. Independent variables (Predictors) 
1. Gender (sex): Two level categorical variable: Male/Female; M=0 F=1 
 
2. Applicant employment category (app_cat): Two level categorical variable: (A): 
white collar and construction, (Bi/ Bii): maids and drivers/ food handlers and 
hygienic staff. Also, each occupation was analyzed separately prior to being 
classified according to visa categories mentioned earlier. 
 
3. Nationality (Nat): categories based on WHO classification: SEAR: WHO South-
East Asia Region, EMR: WHO Eastern Mediterranean Region, AFR: WHO 
African region, WPR: WHO Western Pacific Region, EUR: WHO European 
Region, AMR: WHO region of America. Also, nationality was analyzed 
separately prior to being classified as regional WHO classification.  
 
4. Visa type (visa_type_nr): Two level categorical variable: New/Renew 
 
5. Age: continuous variable 
6. (agecate3): Two level categorical variable: (18-34); (35-64) years 
 
7. Chest X-ray final evaluation (CXR_Final_eval): Two level categorical 





8. IGRA Result (IGRA_VAL): Two level categorical variable: negative/ positive 
 
9. TST observation (TST_observation): Two level categorical variable: Negative 
indurations (0-14) mm; and positive indurations (15-40) mm 
10. (tstobservation): continuous variable for TST 
11. Sputum smear AFB value (AFB_smear_val): Two level categorical variable: 
negative/positive 
12. Disease Prevention and Screening Centers (Facility_DPSCS): Two level 
categorical variable 
 
B. Outcome variable (Dependent)  
MTB= 0 when sputum culture is negative (TB culture value shows no growth of MTB) 
MTB=1 when sputum culture is positive (TB culture value shows growth of MTB) 
 
 





The final data set included the following variables: sex, applicant employment category (A vs. 
Bi/Bii), nationality, visa type (new vs. renew), and age category, chest X-ray evaluation by 
radiologist, IGRA (QFT-GIT) value, TST observation, sputum smear AFB result and screening 
centers DPSCs in which the tests were conducted.  
Statistical software and data analysis plan 
Descriptive summary statistic and sample distribution characteristics 
Stata 11 statistical software package was used as the main program for data management and 
analysis in the study. Descriptive summary of the data was produced (using Frequency and 
percentages for categorical variables and mean and standard deviation (SD), median, 
interquartile range (IQR) and variance for continuous variables).
47
 Descriptive summary 
statistics helped in the assessment of the skewness and the kurtosis of the sample and the 
identification of possible outliers and/or other characteristics that may affect the outcome 
variable. 
Exploratory data analysis of the continuous predictors in the data was then intended to further 
diagnose skewness and to identify outliers. As most statistical methods perform best when 
applied on normally distributed samples, normality tests and transformations of the continuous 
variables were assessed in our study sample using graphs such as histogram and boxplot. The 
transformation was assessed to find the best match of a normally distributed sample. The 
transformation choice was further supported by the generation of the histograms and normal 
distribution curve for each transformation and by boxplot graphs.
47
 Pearson‘s chi-square tests 




with age group category; younger (18-34 years and older 35-64 years), to identify the 
characteristics of the study sample. 
Testing hypothesis by cross tabulation (the validity of IGRA, TST, and chest X-ray) 
In order to test the hypothesis of IGRA being more sensitive than TST, cross-tabulation of the 
predictors of interest with MTB using Pearson‘s chi-square and Fisher‘s exact tests were done to 
calculate the sensitivity, specificity, PPV, NPV, positive and negative likelihood ratios. Similar 
steps were followed to generate the validity measures for chest X-ray. To test the level of 
agreement between IGRA (QFT-GIT) and TST a kappa statistic was calculated. Interpretation of 
kappa was based on a commonly cited scale in which kappa of less than zero is interpreted as 
poor, kappa of (0.01-0.20) is interpreted as slight agreement, kappa of (0.21-0.40) is interpreted 
as fair agreement, kappa of (0.41-0.60) is interpreted as moderate agreement, kappa of (0.61-





Simple and multiple regression analysis to identify predictors of MTB 
Simple and multiple regression analysis of the two continuous variables were intended to the 
relationship of each the continuous variables to the predictors of interest. The two continuous 
variables were then grouped into two categories and bivariate cross-tabulation analyses using 
Pearson‘s chi-square tests and Fisher‘s exact tests tested the relationship of each independent 
variable to the outcome, presence/absence of MTB. The Variance Influence Factor (VIF) was 
used to check for multi-collinearity among the predictors and pseudo-regression and correlation 
analyses were performed in our study.
47




to calculate the predicted values and the residuals. This was followed by the multiple regression 
model analysis and the test of correlation in the sample. A 95% confidence interval was used for 
the prevalence estimates. 
Logistic regression analysis and MTB 
Logistic regression was used to estimate the crude and adjusted relative odds in order to measure 
the effect of the factors included in the analysis. Logistic regression was used to produce the 
crude and relative odds of MTB. Similarly, the crude and relative odds of MTB per age category 
were measured. Factors of interest such as age category, chest X-ray evaluation by a radiologist, 
IGRA (QFT-GIT) value, TST observation and sputum smear AFB were finally included in the 
logistic model. Wald tests were then performed initially to test each model separately and this 
was then followed by the likelihood ratio tests for the nested logistic regression model to test the 
scientific hypothesis and to confirm the Wald test results.   
 
Data limitations 
Cross-sectional studies are usually considered as quick and relatively inexpensive to conduct and 
can give a picture of the health situation at hand.
49
 Those studies are generally done to determine 
the prevalence of a disease and are useful in the identification of certain associations (putative 
risk factors) that can be studied more specifically using cohort or randomized controlled trials.
49
 
On the other hand, a couple of disadvantages might be encountered because of the study design 
itself one example could be the lack of the ability of generalizability.
49
 Other examples include 
unequal distributions of confounders and unequal group sizes.
49 




be made using cross-sectional data; the predictors/risk factors and the outcomes are both 
collected at the same time.  
The results of the initial bivariate cross-tabulation analyses highlighted the presence of several 
cells in which there was an insufficient sample size to support analysis by the outcome of 
interest. Reclassification of TST observation, age category, applicant employment category, 
nationality, and sputum smear (AFB) result was needed to avoid inadequate numbers in certain 
cells and to allow for subsequent logistic regression analyses.  
Another limitation is the specificity of the test as it was underestimated most probably due to the 
prevalence of latent tuberculosis and or old MTB in the sample. Moreover, it was difficult to 
explore the relationship of the diseases to an occupation. This was challenging given the wide 
range of available occupations (445 occupations) and the small and inadequate number of cells 
needed for analysis. Therefore, analysis was restricted to using applicant occupational categories 
instead.  
The dataset was restricted to one-year duration although the intention initially was to assemble a 
dataset for three years. This was attributed to the fact that some visa applicants renew their visa 
on a yearly basis such as those who are 60 years and older. Including multiple years will lead to a 
duplication of subjects in the study sample and as per consultation with the IT personnel in 
DOH/HAAD it was recommended to restrict the dataset to a one-year interval to avoid this 
disadvantage. The use of multiple years for creating such a multi-year dataset will implicate 
further efforts and extra unplanned work time that can extend beyond working hours for IT 




Ethical considerations and protection of human rights 
Data on demographics, visa type information and final disease status of MTB collected through 
the standard visa screening services are uploaded and made available in the DOH/HAAD 
electronic system. Each screened individual is linked to the system using a unique identifier 
code. The data used for this study was obtained from the existing visa screening data available in 
the DOH/HAAD electronic system. Data were de-identified to eliminate personal information 
(such as name, contact information, sponsor details and passport number etc., ...) by IT experts in 
the surveillance and statistics section in DOH/HAAD. The data was stored on a secure server 
protected by limited access and strong password systems.  Data were coded when possible.   
Data remained in a DOH/HAAD secured PC and was not transferred to a personal computer. 
Portable electronic devices did not contain identifiable information. The principal investigator 
(Huda Alshemeili) had access only on the decoded (de-identified) data provided by DOH/HAAD 
as an excel sheet secured by a password. The principal investigator was instructed to inform the 
Ethical Committee and submit a revised and complete application for approval of changes in the 
project occurred which might affect patient safety or privacy, or the purpose of the project. The 
principal investigator completed an ethical training course at John Hopkins University prior to 
initiating the request to conduct the study. 
Ethical approval, IRB 
The local Institutional Review Board (IRB) at Al-Ain University approved this study, giving it 
Exempt Status, which was accepted by the Johns Hopkins Bloomberg School of Public Health, 





The hypotheses of the study were established based on evidence from the literature. According to 
the TB conceptual framework, two main categories are recognized as risk factors for TB 
including: those that result in an increased risk of exposure to TB (such as immigrants coming 
from high endemic regions and healthcare workers), and those factors that increase the risk of 
developing active disease (such as age younger than 4 years and diabetes).  
Our study is a cross-sectional study that analyzed data routinely collected by DOH/HAAD on 
adults (18-64) years seeking a residency visa (new or renewal) in the Emirate of Abu Dhabi from 
January – December 2013. Test procedures performed on abnormal and suspicious Chest X-ray 
findings included TST, IGRA and sputum collection for AFB smears and cultures. Data 
management using Excel and the Stata 11 statistical software package finally yielded a total of 
12 independent (predictors) variables and MTB was the dependent (outcome) variable signifying 
the presence or the absence of Mycobacterium tuberculosis infection based on the gold standard 
test (i.e., the sputum culture). Several statistical analytical methods such as cross-tabulation, 
simple and multiple regression analysis, and logistic regression analysis were applied in order to 
generate results for chapter 4. The dataset was restricted to one-year duration and is considered 
as an unavoidable limitation. Unfortunately, information on known risk factors for TB such as 
smoking and diabetes were not available for analysis. The IRB board approval was obtained 









Chapter 4 will provide the results needed to answer the hypotheses mentioned earlier in chapter 3 
and the results are, therefore, divided into three sections and the conclusions of main findings 
will be provided at the end of the chapter. 
Section (A): Demographic characteristics by age category. This section will highlight the results 
of the descriptive analysis of the main variables by age categories as presented in table (4.1.1) 
and related graphs.   
Section (B): IGRA and TST validity/Chest X-ray validity. This section will present the validity of 
IGRA and TST results in graphs and related tables. Table (4.2) shows the sensitivity, specificity, 
negative predictive value (NPV), the positive predictive value (PPV), the negative likelihood 
ratio (NLR), the positive likelihood ratio (PLR) and then validity by age category in the table 
(4.3). This will be followed by the validity of parallel testing of TST and IGRA and per age 
category as demonstrated in Tables (4.4), (4.5) and (4.6) then kappa agreement of IGRA and 
TST.  Finally, the validity of chest X-ray will be addressed in the table (4.7). Tables 4.8.1- 4.8.6 
will present data related nationality and gender, occupation and MTB and WHO regions by MTB 
and gender. The tables will also provide information about the results of the analysis of the 
continuous variables in the study sample.  
Section (C): Predictors of MTB. This section will explore the relationship of the predictors of 




crude and adjusted relative odds of MTB will be provided in the table (4.9) and by age category 
in the table (4.10).  
Results 
A. Demographic characteristics by age category 
The study sample comprises 2,596 (170/100000) individuals with abnormal chest X-rays who 
met all eligibility criteria, (Table 4.1.1). 
 
  





In our study, males constituted the largest percentage of visa applicants compared to females 
(81.8% vs 18.2%) (Table 4.1.1) (Figure 4.1.1). High gender imbalance was noticed in our study 
as more males were present in the older age group category and male/female ratio was 3.8 for the 
(18-34) age group and 5.5 for the age group (35-64) (Table 4.1.1) (Figure 4.1.1). 
 
 
The percentage of younger vs. older applicants was almost comparable among the majority of 
occupations yet a higher percentage of younger individuals were working as servants and 
babysitters, (P<0.001) (Figure 4.1.2). A higher percentage of older individuals were among 
applicant category A: white collar and construction compared to applicant category Bi/Bii: maids 











A higher percentage of older individuals came from SEAR compared to other WHO regions, 
(P<0.028) (Figure 4.1.3). 
 
 
Older individuals were more commonly found in the renewal visa category compared to younger 
individuals, (P<0.001) (Figure 4.1.4). On the other hand, younger individuals were mainly found 
in the new visa applicant category, (P<0.001) (Figure 4.1.4). 
Figure 4.1. 2: Occupation and Age category/ Applicant category A vs. Bi/Bii and Age 
category 
 







A higher percentage of younger individuals were suspected to have MTB by chest X-ray 
evaluation report, (P<0.001) (Figure 4.1.5). 
 
 
A higher percentage of younger individuals also had positive IGRA results compared to older 
individuals, (P<0.027) (Figure 4.1.6). 
 
Figure 4.1. 4: Visa: New vs. Renew and Age category 
 








A slightly higher percentage of younger individuals had positive TST results compared to older 
individuals, (P=0.066, not significant) (Figure 4.1.7). 
 
 
A slightly higher percentage of younger individuals had positive sputum AFB smear results 
compared to older individuals, (P=0.052, not significant) (Figure 4.1.8). 
Figure 4.1. 6: IGRA value and Age category 
 







B. The validity of IGRA, TST and chest X-ray 
The validity of IGRA and TST by sex 
In our sample, IGRA is more sensitive among females (78.3%) compared to males (71.6%) 
(Table 4.1.2) (Figure 4.2.1). TST, on the other hand, has less sensitivity than IGRA and TST is 
of a comparable sensitivity among males (58.5%) and females (61.7%) (Table 4.1.2) (Figure 
4.2.1). 
 
Figure 4.1. 8: Sputum AFB smear and Age category 
 








The validity of IGRA and TST by visa type 
When looking at the visa type in our sample, IGRA is slightly more sensitive among new visa 
applicants (74.1%) compared to renewal (70.9%) (Table 4.1.3) (Figure 4.3.1). TST, on the other 
hand, has lower sensitivity than IGRA and TST is more sensitive among new visa applicants 




Figure 4.2. 1: IGRA and TST sensitivity and specificity by sex 
 






The validity of IGRA and TST by country 
When looking at the visa applicants from Pakistan, IGRA is more sensitive (74.1%) than TST 
(52.6%) (Table 4.1.4). Similarly, IGRA is more sensitive (78.4%) than TST (59.5%) in visa 
applicants from Bangladesh (Table 4.1.4). IGRA is also more sensitive (90.9%) than TST 
(63.7%) among visa applicants from Indonesia (Table 4.1.4). 
 






When looking at the visa type by country, majority of applicants for new visa were from 
Pakistan, the Philippines and Indonesia while applicants for visa renewal were from Bangladesh, 
Ethiopia and Egypt (Table 4.1.5).  







The validity of IGRA and TST by WHO regions  
When looking at the applicants for WHO region perspective in our sample, IGRA is slightly 
more sensitive among visa applicants in AFR/EMR regions (76.7%) compared to SEAR (70.4%) 
and other regions (Table 4.1.6). TST, on the other hand, is of a lesser sensitivity in all WHO 
regions and is of lesser sensitivity when compared to IGRA (Table 4.1.6). 
 






The validity of IGRA and TST by Chest X-ray evaluations  
When looking at the chest X-ray for applicants in our sample, IGRA is more sensitive among 
visa applicants with a chest X-ray evaluation of abnormal Not/Old TB (85.3%) than those with 
chest X-ray evaluation of Suspicion of TB (67.7%) (Table 4.1.7).  TST, on the other hand, is of a 
lesser sensitivity than IGRA and TST is of a comparable sensitivity among those with a chest X-
ray evaluation of abnormal Not/Old TB (Table 4.1.7). 
 
 
When looking at the results for the applicants after merge of the first two TST categories in our 
sample, we found that among those diagnose with MTB and had negative IGRA: 46.9% had 
Table 4.1. 6: The validity of IGRA and TST by WHO regions 
 





negative TST and 53.1% had positive TST result, (P<0.001) (Figure 4.4.1).   Among those 
diagnosed with MTB and had positive IGRA: 38.7% had negative TST and 61.3% had positive 
TST result, (P=0.930, not significant) (Figure 4.4.1). 
 
 
The validity of IGRA and TST by sputum AFB smear results  
When exploring the relationship between AFB smear results and IGRA we found that among 
those diagnosed with MTB disease: 14.3% had positive AFB smear results among those with 
negative IGRA compared to 23.7% positive AFB smear results among those with positive IGRA, 
(P<0.001) (Figure 4.5.1). 






Among those diagnosed with MTB disease: 24.5% had positive AFB smear results in the TST 
(0-14) mm category and 18.9% in the (15-40) mm category, (P<0.001) (Figure 4.6.1). 
 
 
Figure 4.5. 1: Sputum AFB smears by MTB and IGRA value 
 





When looking at the sputum AFB smear results in relation to TST for applicants in our sample, 
TST sensitivity is 60.8%, (P<0.001) among those with negative AFB smear results compared to 
52.6% in the positive AFB smear results, (P=0.633, not significant) (Figure 4.7.1).  
 
 
Table 4.2.1 shows the sensitivity, specificity, the negative likelihood ratio (NLR), the positive 
likelihood ratio (PLR), negative predictive value (NPV), the positive predictive value (PPV) of 
all the screening tests used in the study. IGRA (QFT-GIT) sensitivity is 72.7%, (95% CI: 68.8-
77.2) compared to TST sensitivity of 59.0%, (95% CI: 53.8-64.2). Therefore, and as we 
assumed earlier, IGRA is more sensitive than TST in detecting MTB among adults during the 
visa screening process. 
When considering IGRA predictive values in our study, an individual's prior probability of 
having the disease is 0.14 and is modified to 0.169 if he/she has a positive IGRA test result. An 





individual's prior probability of not having the disease is 0.86 and is modified to 0.91 if he/she 
has a negative IGRA test result.  Similarly, when considering TST predictive values in our study, 
an individual's prior probability of having the disease is 0.14 and is modified to 0.17 if he/she has 
a positive TST test result and an individual's prior probability of not having the disease is 0.86 





Table 4.3.1 shows the sensitivity, specificity, the negative likelihood ratio (NLR), the positive 
likelihood ratio (PLR) by age group. Among the younger age group (18-34) years IGRA (QFT-
GIT) sensitivity was 78.1%, (95% CI: 72.2-83.2).  IGRA (QFT-GIT) sensitivity was better than 
TST sensitivity and was even better than IGRA (QFT-GIT) sensitivity in the older age group in 
the study. Therefore, and as we assumed earlier, IGRA and TST sensitivity were reduced as 
the applicants aged. 







Simultaneous (parallel) test: IGRA (QFT-GIT) and TST 
The net sensitivity of parallel testing with both IGRA (QFT-GIT) and TST is 88.8% (Table 
4.4.1). The net sensitivity of parallel testing with both IGRA (QFT-GIT) and TST for the 
younger age group (18-34) years was even higher, 91.5% (Table 4.5.1 and Table 4.6.1). IGRA 
(QFT-GIT) therefore may have a ‗rule out‘ value for active tuberculosis when used with other 
investigations. Therefore, and as we assumed earlier, simultaneous testing (parallel) with 
IGRA (QFT-GIT) and TST had improved net sensitivity for detecting MTB among adults 
during the visa screening process. 
 












Kappa agreement between IGRA (QFT-GIT) and TST is 0.33 and (95% CI: 0.29-0.36) which is 
considered as only fair concordance.   
Table 4.4. 1: Sensitivity and specificity of IGRA/TST (parallel and serial) 
Table 4.5. 1: Sensitivity and specificity of IGRA/TST (parallel and serial) in 
younger age category (18-34) years 
 
Table 4.6. 1: Sensitivity and specificity of IGRA/TST (parallel and serial) in older 





The validity of chest X-ray  
When considering the performance of chest X-ray in this study (using the sputum culture as the 
gold standard test), the sensitivity and specificity of chest X-ray is 71.6% (95% CI: 66.6–76.2) 





Therefore, we still consider that chest X-ray has a good sensitivity in detecting TB among 
adults during the screening for visa purposes as we assumed earlier yet the role of chest X-ray 
in our study was not adequate due to low sensitivity and modest accuracy (only 57%). 
 
When considering chest X-ray predictive values in our study, an individual's prior probability of 
having the disease is 0.14 and is modified to 0.20 if he/she has abnormal chest X-ray evaluation 
result. An individual's prior probability of not having the disease is 0.86 and is modified to 0.92 
if he/she has a negative chest X-ray evaluation. The net sensitivity of parallel testing with both 
IGRA (QFT-GIT) and chest x-ray is 92.2%. The accuracy of chest X-ray in our study is modest 
(only 57%) and the accuracy of IGRA and TST are 47% and 55% respectively.  





C. Predictors of MTB 
A total of 359 cases were eventually confirmed to have MTB based on positive sputum culture 
result in our study. Thus, 13.8% of applicants with abnormal chest X-ray were diagnosed with 
tuberculosis, compared to 2,237 individuals (86.2%) confirmed as MTB negative based on 
negative sputum culture results.  When comparing the proportion of adults diagnosed to have 
MTB in the sample to those who do not have the disease; the prevalence of the disease was 14% 
(359/2,596) and the (95% CI: 0.13-0.15). Around 14% (299/2124) of males were diagnosed to 
have MTB compared to 13% (60/472) in females, a non-significant difference (P=0.437). 
Around two-thirds of MTB cases occurred among the younger age group (18-34) years, 
(P<0.001) (Figure 4.8.1). 
 
 





Among MTB positive cases, the mean age is 33.2 (SD ±9.87) years and the median age is 30.4 
(IQR 13.5-14.4). Those diagnosed with MTB were younger than individuals proven not having 
the disease (Figure 4.9.1). 
 
Almost two-thirds of the applicants in the study came from Pakistan and India. Nearly two-thirds 
of males in the sample were from Pakistan and India while almost 50% of females were from the 













In our study sample, the majority of applicants who applied for residency in Abu Dhabi to work 
in construction and were employed as workers, laborers or cleaners and helpers came mainly 
from Pakistan, India, Bangladesh, and Nepal. Drivers were mainly from Pakistan and 
Afghanistan while servants and babysitters were from Ethiopia, Indonesia and, Philippines.  
Almost 48% of MTB cases occurred among applicants working in construction and were 
employed as workers, laborers or cleaners and helpers, (P=0.315, not significant) (Table 4.8.2). 
 






For the sake of convenience, the applicant category grouping of A and Bi Bii (as in DOH/HAAD 
visa standard) was used instead of occupation in the analysis due to limited numbers in cells of 
occupation variable.  Among the two applicant employment categories, almost 80% came from 
group A (white collar and construction) and the majority of MTB cases belongs to this group as 
well, (P=0.32, not significant) (Figure 4.10.1). 
 
 
Figure 4.10. 1: Applicant category A vs. Bi/Bii by MTB 
 





Considering the nationality and MTB diagnosis in the sample, approximately 60% of MTB cases 
came from Pakistan and India. A smaller percentage (12.8%) of MTB cases were diagnosed 
among individuals coming from the Philippines and 10.3% of cases were from Bangladesh, 
(P<0.001) (Table 4.8.3). 
 
 
When considering the WHO regional classification of nationality and MTB diagnosis in the 
sample, approximately 47% of MTB cases came from countries of the South East Asia Region 
(SEAR) followed by the African and Eastern Mediterranean Regions (39%). However, there 
were no differences in MTB by WHO region of origin, (P=0.703, not significant). Similarly, 
there were no differences in MTB by sex and WHO region of origin, (P=0.895, not significant) 
(Fig. 4.11.1) (Table 4.8.4).  
 
 









When comparing between the visa type applicants, more cases were detected among the new 
visa applicants.  Around 56% of MTB cases occurred among the new visa applicants compared 
to 44% positive cases in the renewal visa applicants, (P=0.54, not significant) (Figure 4.12.1). 
Figure 4.11. 1: WHO regions by sex and MTB 







More than two-thirds of confirmed MTB cases occurred among those with a chest X-ray 
evaluation of Suspicion of TB, (P<0.001) (Figure 4.13.1). 
 
 
Figure 4.12. 1: Visa: New vs. Renew and MTB 
 





Similarly, more than two-thirds of confirmed MTB cases occurred among applicants with IGRA 
positive test, (P<0.001) (Figure 4.14.1). 
 
 
Almost two-thirds of confirmed MTB cases had TST positive test (59%) compared to 45% of 














Positive AFB smear test was found mainly in confirmed MTB cases compared to those without 
the disease, (P<0.001) (Figure 4.16.1). 
 
 
Figure 4.15. 1: TST categories and MTB 
 





The Two-sample t-test used to assess the difference in mean for the continuous variable 
TST(tstobservation) in the sample showed a non-significant association for gender, applicant 
employment category (A vs. Bi/Bii), age category and visa type (new vs. renew) (Table 4.8.5). 
However, individuals with IGRA positive had a significantly higher TST mean compared to 
those with IGRA negative result, (P<0.001) (Table 4.8.5). Similarly, individuals with a 
diagnosis of the MTB disease had a significantly higher TST mean compared to those diagnosed 
with non-MTB disease, (P<0.001) (Table 4.8.5).  On the other hand, those with chest X-ray 
evaluation of Abnormal Not/Old TB had a significantly lower TST mean compared to those with 
chest evaluation of Suspicion of TB, (P<0.001) (Table 4.8.5). The results were further supported 
and the conclusion was checked using non-parametric tests; the Mann-Whitney U test and the 






Similarly, the Two-sample t-test used to assess the difference in mean for age, a continuous 
variable in the sample, showed that females were significantly younger than males and that 
applicants for a renewal visa were older than those applying for new visa, (P<0.001) (Table 
4.8.6). Similarly, individuals with IGRA positive were younger than those with IGRA negative 
result, (P<0.012) (Table 4.8.6). Also, individuals with a diagnosis of MTB disease were younger 
than those diagnosed with non-MTB disease, (P<0.001) (Table 4.8.6). On the other hand, those 
with chest X-ray evaluation of Abnormal Not/Old TB were older than those with chest 
evaluation of Suspicion of TB, (P<0.001) (Table 4.8.6).    







The ANOVA test showed a non-significant difference in the mean of age for gender, visa type 
(new vs. renew) and applicant employment category A vs. Bi/Bii. On the other hand, ANOVA 
test showed a significant difference in the mean of age for IGRA, the diagnosis of MTB and 
chest X-ray evaluation of Suspicion of TB. While holding age constant, multiple linear 
regression showed a non-significant association between TST and other variables including 
gender, visa type (new vs. renew) and applicant employment category A vs. Bi/Bii. In the study 
sample, factors including gender, applicant employment category, nationality, visa type and 
DPSCs did not show significant association in cross tabulation and did not show significant 





results running the logistic regression and therefore were not included in the final analysis.  The 














β ˆˆˆˆˆˆMTB   
where the dependent variable (Y) is MTB= Mycobacterium tuberculosis categorized into two 
groups: (MTB= 0 when sputum culture is negative) and (MTB=1 when sputum culture is 
positive) and the independent variables (Xs) as follows: 
agecate3= age categorized into two groups: (18-34) and (35-64) years;  
CXR_Final= chest X-ray evaluation categorized into two groups: (Suspicion of TB) and 
(Abnormal Not/Old TB);  
IGRA_VAL= IGRA results reported as: (negative) and (positive);  
TST_Observation= TST results categorized into two groups: negative indurations (0-14) mm and 
positive indurations (15-40) mm; and  
AFB_Smear_val= AFB sputum smear results reported as: (negative) and (positive). 
 
Consistent with the previously mentioned results, older individuals (35-64) years had a lower 
probability of having MTB when compared to younger individuals (18-34) years (OR = 0.62; 




4.8). Therefore, as we assumed earlier, younger visa applicant carried a higher risk of TB 
compared to older visa applicants. 
 
 
As expected, individuals with chest X-ray evaluation of Abnormal Not/Old TB had a lower 
probability of MTB when compared to individuals with a chest X-ray evaluation of Suspicion of 
TB group (OR= 0.35; 95% CI: 0.27 – 0.47, P<0.001). (Table 4.9)  
More than two-thirds of MTB cases had a positive IGRA test, (P<0.001). As expected, IGRA 
(QFT-GIT) was significantly higher among those diagnosed with MTB compared to those 
without MTB which infers a possible association between positive IGRA (QFT-GIT) result and 




being diagnosed with MTB (OR= 1.5; 95% CI: 1.14 - 2.01, (P<0.004). A similar relationship 
was shown for a positive TST value (15-40 mm) among those confirmed to have MTB compared 
to those without MTB (OR= 1.4; 95% CI: 1.17- 2.0, (P<0.002) (Table 4.9). 
Table 4.10 shows the relationship of age groups to MTB diagnosis, IGRA and TST results. 
 
 
More than two-thirds of younger individuals (18-34) years diagnosed with MTB had a positive 
IGRA (QFT-GIT), (P<0.001). The odds of positive IGRA (QFT-GIT) result among MTB 
positive cases in the younger age group (18-34) years is 2.6, (P<0.001) which infers a possible 
association between positive IGRA (QFT-GIT) result and being diagnosed with MTB in younger 
individuals. (Table 4.10) A similar relationship is noticed for a positive TST value (15-40 mm) 
among younger individuals (18-34) diagnosed with MTB, (P<0.001) (Table 4.10). In contrast, 
the IGRA was not significantly associated with being an MTB case for those in the older age 
group and only positive TST result was significant in this age group (Table 4.10). 






In our study, males constituted a larger percentage of visa applicants compared to females. Older 
individuals were more commonly found in the renewal visa category compared to younger 
individuals. Majority of applicants for new visa were from Pakistan, the Philippines and 
Indonesia while applicants for visa renewal were from Bangladesh, Ethiopia and Egypt. A higher 
percentage of younger individuals were working as servants and babysitters. When compared to 
older visa applicants, a higher percentage of younger individuals were suspected to have MTB 
by chest X-ray evaluation report and had positive IGRA (QFT-GIT) result.  
 
IGRA was shown to be more sensitive than TST, but the sensitivity is reduced in the older age 
group. Simultaneous testing (parallel) with IGRA (QFT-GIT) and TST had a high net sensitivity 
(88.8%) for detecting MTB among adults. The net sensitivity of simultaneous (parallel) testing 
with both IGRA (QFT-GIT) and TST for the younger age group was even higher (91.6%). 
However, Kappa agreement between IGRA (QFT-GIT) and TST in the study is considered as 
only fair concordance.  Chest X-ray had a good yet lower sensitivity in detecting TB among 
adults compared to findings in other studies. Older individuals (35-64) years had a lower 













Chapter 5 will provide a summary of the key findings and will provide a discussion of this 
study‘s findings in the context of the currently available literature. This chapter will initially 
address the implications of economic growth in the United Arab Emirates and the subsequent 
growth of population due to immigration. This will be followed by a reflection of the key 
findings of the study sample in three sections:  
Section (A): Discussion of demographic characteristics by age category. This section will 
discuss the main demographic findings in the study in comparison to the reported findings 
internationally.   
Section (B): Discussion of the validity measures. This section will present and discuss the 
validity of IGRA and TST, the predictive values and likelihood ratio. The discussion of the 
simultaneous testing results of our study in comparison to other studies will be addressed. 
Similarly, the validity measures of chest X-ray will be discussed. 
Section (C): MTB screening in relation to other investigations. This section will discuss the 
main findings regarding MTB results in the study in relation to other investigations and other 
studies in the context of current literature.  





Economic growth and immigration in the UAE 
The blessing of wise leadership in the United Arab Emirates (UAE) supported by the wealth of 
oil contributed significantly to the rapid growth of the population and its related services in 
multiple sectors.
50
 The UAE, therefore, captured the attention of the world as a rapidly growing 
country with high potential towards excellence and innovation.
50
 For the past 40 years, a 
significant economic growth in the United Arab Emirates in several sectors including the 
petroleum, construction and healthcare industries.
50
 Rapid industrialization was therefore 
brought by and supported by the recruitment of foreign expertise and manpower from all over 
the globe to satisfy the rapid demand of the economic and industrial development.
50
 To satisfy 
the manpower demands of numerous projects, e.g., in the construction and service industries, low 
skilled or unskilled laborers were often recruited from less developed countries.
50
   
The United Arab Emirates‘ culture is based on the family as the core element in the community. 
The extended family had constantly been the source of security and vitality of the Arabian tribes 
in the country. In the past, the members of an extended family used to share the same house. In 
recent years and due to the growth in of the local population, and subsequently a growth in the 
demand for servants and drivers, each family would have its own house. However, individuals of 
the same family would be neighbors in order to protect the intimacy of family relationships.  
Section (A): Discussion of demographic characteristics by age category 
As a result of the rapid economic growth and the urbanization of the local families in the 
country, the UAE population had increased considerably expanding from 4.1 million in 2005, to 










The United Arab Emirates is recognized for its highly diverse population where only 10% are 
UAE nationals and the rest is made up of expatriates.
51, 52
 Globally, the UAE was ranked as a 
country with the highest gender imbalance with a male/female ratio of 2.2, or 2.75 for the 15-65 
age group.
52
 In our study, males constituted the largest percentage of visa applicants compared to 
females 81.8% vs 18.2% and male/female ratio of 3.8 for the (18-34) age group and 5.5 for the 
age group (35-64) which exceeds the reported ratios reported above. In our study, a higher 
percentage of younger individuals were found among those applying for a new residency visa 
while older individuals were more predominantly in the renewal category. 
A cross-sectional study that recruited immigrant females 18 years and older in Al- Ain to study 
the prevalence of diabetes among immigrant females according to their residency duration 
reported that females from South Asia and the Philippines comprised a significant proportion of 
immigrants that were typically employed as housemaids (female servants responsible for 
common household work).
53
 In our study, the percentage of younger vs. older applicants was 
almost comparable among the majority of occupations yet a higher percentage of younger 
individuals were employed as servants and babysitters mainly from Ethiopia, Indonesia, and the 
Philippines. 
UAE ranked as having the 7th highest net migration rate in the world where the majority was 
from South Asian countries (58%) followed by other Asians (17%) and expatriates from western 
countries (8.5%).
52




almost half of the visa applicants were from the South East Asian Region. In our study, nearly 
two-thirds of males in the sample were from Pakistan and India while almost 50% of females 
were from the Philippines. 
In a study conducted among immigrant applicants in Vietnam bound for the United States, there 
were considerably fewer adult applicants who had evidence of TB on chest X-ray (22%) than 
those who had a positive TST result (58%) or a positive QFT- GIT (28%).
54
 Accordingly, the 
previous study reported that their screening algorithm had lost a considerable number of LTBI 




Similarly, a higher percentage of younger individuals in our study were suspected to have MTB 
by chest X-ray evaluation reports and a higher percentage of positive IGRA/TST test results 
occurred among them compared to older individuals. Moreover, in the younger age category 
with the diagnosis of MTB, (54.2%) had evidence on chest X-ray compared those who had a 
positive IGRA (QFT-GIT) (59.6%), a smaller difference compared to the findings of the study 
done among the immigrant applicants in Vietnam bound for the United States.  
 
Section (B): Discussion of the validity measures  
A. The Validity of IGRA (QFT-GIT) and TST 
Sensitivity of a test in the study was defined as the proportion of individuals with a positive test 
(IGRA/TST) result among those with positive sputum culture test for tuberculosis, and 




among those who had active tuberculosis disease ruled out (i.e., a negative sputum culture test 
for tuberculosis) (Figure 5.1). 
 
 
In a systematic review focusing on individuals living in low- and middle-income countries, the 
highest-quality evidence from individuals with suspected tuberculosis demonstrated a sensitivity 
of 69%–83% and specificity of 52%–61% for IGRAs in the diagnosis of active tuberculosis. 
37
  
De Keyser, De Keyser, and De Baets explored a meta-analysis based on data derived from a 
systematic literature review to examine the value of TST versus two types of IGRAs in the 
diagnosis of TB infection.
15
 They included 11 studies that compared the sensitivity and 
specificity of TST and QFT-GIT.
15
 Azghay et al. used retrospective data obtained from patients 
admitted with pulmonary or extra-pulmonary TB in a high TB prevalence region in France to 





analyze the performance of the QuantiFERON-TB Gold In-Tube assay (QFT-GIT) in the 
diagnosis of tuberculosis disease.
23
  
The sensitivity of IGRA (QFT-GIT) obtained in our study 72.7% (95% CI: 68.8-77.2) was 
similar to (yet slightly lower) the sensitivity reported by the previously mentioned studies: De 
Keyser, De Keyser, and De Baets found a pooled sensitivity of 75% while Azghay et al. found a 
sensitivity of 85% (Figure 5.2 and Figure 5.3).
15, 23
   
De Keyser, De Keyser and, De Baets reported a higher pooled sensitivity of IGRA (QFT-GIT) 
[75% (95% CI: 61–86)] compared to the pooled sensitivity of TST [64% (48–78)].
15 
Similarly, in 
our study, IGRA (QFT-GIT) sensitivity is higher than TST (Table 5.1) and (Figure 5.2 and 
Figure 5.3).  
 
 












In our sample, IGRA is more sensitive among females compared to males yet TST is of a 
comparable sensitivity (Table 5.1). Similarly, IGRA is more sensitive among younger visa 
applicants compared to older visa applicants and IGRA is more sensitive than TST among the 
visa applicants for administration and sales, construction and workers, technicians, drivers and 
guards, servants and babysitters.  





In our sample, IGRA is more sensitive among visa applicants from Pakistan, Bangladesh, and 
Indonesia. In addition, IGRA is slightly more sensitive among visa applicants in AFR/EMR 
regions compared to SEAR and other regions. TST, on the other hand, is of a lesser sensitivity in 
all WHO regions and is of lesser sensitivity when compared to IGRA. When looking at the visa 
status for applicants in our sample, IGRA is slightly more sensitive among new visa applicants 
compared to renewal applicants. TST, on the other hand, is of lesser sensitivity than IGRA and 
TST is more sensitive among new visa applicants compared to renewals (Table 5.1). A 
retrospective study comparing two screening strategies for TB contact tracing was conducted at 
the TB Unit in Barcelona (Spain) between January 2006 and December 2010 added proof on the 
advantage of implementing QFT-GIT to target BCG-vaccinated contacts for preventive 
therapy.
55
 The approach mentioned by Muñoz et al. reduced the exposure to unnecessary 
prophylactic treatment without increasing the risk of consequent active TB.
55
 With a higher 
sensitivity of IGRA (QFT-GIT), fewer false-negative results are expected. Consequently, 
including IGRA (QFT-GIT) in screening algorithms should lead to fewer missed cases of LTBI 




Although IGRA (QFT-GIT) sensitivity is higher than that of TST, the IGRA test cannot be used 
alone to ‗rule out‘ active tuberculosis due to inadequate sensitivity.
23
 It was concluded by two 
systematic reviews that in adults IGRAs must not be used in the diagnostic investigations of 
active TB since a positive IGRA result might not indicate active TB and similarly, a negative 






IGRA tests cannot distinguish between active TB and LTBI and therefore the specificity tends to 
be low in a high prevalence of LTBI.
33, 37
 IGRA (QFT-GIT) specificity in our study (42.6%, 
(95% CI: 40.5-44.6)) (Figure 5.2) was lower than what was reported by De Keyser, De Keyser, 
and De Baets (71%) and Azghay et al. (73%) and therefore cannot be used to ‗rule in‘ active 
disease.
15, 23
   
 
De Keyser et al. reported that the pooled specificities were similar for IGRA (QFT-GIT) and 
TST [71% (62–80) versus 70% (95% CI: 57–81)].
15
 However, the specificity of IGRA (QFT-
GIT) was lower than TST in our study (Table 5.2 and Figure 5.2 and Figure 5.3). This may be 
attributed to the current latent TB (LTBI) and or old TB in the study since among individuals 
have not been proven not to have MTB, 55% of individuals with a chest X-ray evaluation of 






In addition, in our study TST was lower when age was increasing, (P<0.004).   This was further 
supported by the Spearman‘s correlation coefficient test that confirmed that reduction in TST as 
age was increasing, (P<0.01). In our study TST was more sensitive among younger visa 
applicants (62.4%), (P<0.001) compared to older visa applicants (54.8%), (P<0.024).   
 
B. Discussion of the predictive values of IGRA and TST  
In our study, we assessed the positive predictive value (PPV) and the negative predictive value 
(NPV) of TB disease for IGRA (QFT-GIT) and TST in individuals who applied for the residency 




visa in the emirate of Abu Dhabi in 2013.When considering the predictive values of IGRA 
(QFT-GIT) in our study, among individuals who tested positive only 16.9% actually had the 
disease and for those who tested negative, 90.7% did not have the disease. Similarly, when 
considering TST predictive values in our study, among individuals who tested positive only 
17.3% actually had the disease and for those who tested negative, 89.3% did not have the 
disease. 
 
Though the NPV of IGRA in our study was high, this is not sufficient to ‗rule out‘ the disease as 
one in 10 non-MTB cases will be missed for MTB. The PPV of IGRA was low in a study 
conducted in Poland to assess the validity IGRA and TST among culture negative and culture 
positive TB patients.
40
 According to Wlodarczyk et al., the low PPV of IGRA signifies the need 
of using it in combination with other diagnostic methods for the diagnosis of active TB.
40
 
Similarly, the PPV of IGRA (QFT-GIT) and TST are relatively low in our study.  
C. Discussion of the Likelihood ratio of IGRA and TST  
The Positive likelihood ratio (PLR) for IGRA (QFT-GIT) and TST were similar (1.3). Thus, 
positive IGRA (QFT-GIT) and positive TST results are 1.3 times more likely in individuals with 
MTB as compared to those without MTB. Negative likelihood ratio (NLR) for IGRA (QFT-GIT) 
and for TST are (0.6 and 0.7) respectively. Therefore, negative IGRA (QFT-GIT) results are 0.6 
times as likely in individuals with MTB as compared to those without the disease and negative 
TST results are 0.7 times as likely in individuals with MTB as compared to those without the 




to the usefulness value for the diagnosis of active TB (Table 4.3).  Both IGRA (QFT-GIT) and 
TST, therefore, have a limited utility in ‗ruling out‘ or ‗ruling in‘ active TB. 
In this study, the positive likelihood ratio (PLR) for IGRA (QFT-GIT) is 1.3, quite lower than 
the PLR reported by Azghay et al. (PLR was 3.2).
23
 While the negative likelihood ratio (NLR) in 
the study 0.64 is slightly higher than the finding of Azghay M. (PLR was 0.2).
23
 Therefore, 
IGRA (QFT-GIT) test must not be requested routinely for the diagnosis of active TB as the 
positive and negative likelihood ratios, 1.3 and 0.64 respectively, are small and cannot add to the 
usefulness value for the diagnosis of active MTB. A similar rule is applicable for TST test as 
well. These findings are similar to what was reported in the literature in the small number of 
predictive studies where authors concluded that both IGRA and TST are not highly accurate at 
predicting active TB infection. 
15
 In our study as well, the accuracy of IGRA (QFT-GIT) and 
TST in predicting active TB disease is low (47% and 55%, respectively) (Figure 5.2 and Figure 
5.3).  
D. Discussion of simultaneous (parallel) test: IGRA (QFT-GIT) and TST 
In the present study, the sensitivity of simultaneous (parallel) test of IGRA (QFT-GIT) and TST 
is 88.8%. The sensitivity increased to 91.5% when the parallel test was applied to the younger 
individuals (18-34) years. The result is similar to the finding reported by Azghay et al. who 







E. Discussion of Kappa agreement between IGRA (QFT-GIT) and TST 
The use of Pearson‘s r (correlation coefficient) may result in a poor reflection of the agreements 
between raters (tests) resulting in extreme over or underestimations of the true level of agreement 
between raters (tests).
56 
The Kappa statistic, in contrast, is an index used widely for assessing 
agreement between raters/tests when the outcomes are categorical measures as it increases the 
precision of estimates of the association between tests by controlling for random agreement.
56, 57
  
In a study among immigrant applicants in Vietnam bound for the United States, the prevalence of 
MTB infection (both TB and LTBI) based on TST or the QuantiFERON-TB Gold test reported 
Kappa of 0.24 (0.19–0.28), poor agreement.
55
 In our study, Kappa agreement between IGRA 
(QFT-GIT) and TST was 0.33 (95% CI: 0.29-0.36) which is considered as only fair concordance 
and even better than what was reported by Chuke et al.
55
 Positive TST and IGRA negative 
discordance had been attributed to false-positive TST results as a result of BCG vaccination or 
non-tuberculous mycobacteria (NTM) exposure.
54
 On the other hand, in immune suppression, a 
lower TST sensitivity is noticed and negative TST yet positive IGRA discordance had been 
reported.
54




F. Discussion of the validity of chest X-ray 
A case-control study conducted on a cohort of migrants in Australia showed that chest X-ray at 
migration had limited sensitivity for the prediction of subsequent TB.
33
 According to Linh and 
Marks, almost one-third of all consequent cases of TB and one-quarter of consequent cases of 







Chest radiography has good sensitivity yet poor specificity when utilized for the diagnosis of 
pulmonary TB.
32
 In a study done in Kenya assessing the performance of chest X-ray in all 
suspects of tuberculosis (using the sputum culture as the gold standard test), the sensitivity/ 
specificity/ PPV/ NPV of the score ‗any pathology‘ were 92% (95% CI: 90–94), 63% (95% CI: 
58–67), 76% (95% CI: 73–79) and 86% (95% CI: 82–90), respectively.
41
 In our study, the 
sensitivity and specificity of chest X-ray are 71.6% (95% CI: 66.6–76.2) and 54.6% (95% CI: 
52.5–56.7), respectively are lower than what was reported in the literature (Figure 5.4). 
Therefore, we still consider that chest X-ray has good sensitivity in detecting TB among adults 
during the screening for visa purposes as we assumed earlier yet the role of chest X-ray in our 






Despite the presence of a radiological form provided by DOH/HAAD for the radiologist to 
follow, the final chest X-ray evaluation by the radiologist is largely subjective (Appendix 3.12). 
Identification of radiological features that are most sensitive and specific for predicting 
consequent TB would aid in the effective and efficient implementation of a radiographic 
screening program for detecting individuals at higher risk of subsequent reactivation of TB.
33
 
Radiologists working in screening centers need to receive unified, common training. The 
establishment of a concise chest X-ray scoring system related to tuberculosis is needed to 
increase the sensitivity of the current radiological evaluations.  A high negative predictive value 
had been reported for Chest X-ray indicating the presence of active TB.
32
 In our study, when 





considering chest X-ray predictive values, among individuals who tested positive only 20.2% 
actually had the disease and for those who tested negative, 92.3% did not have the disease. 
Section (C): MTB screening in relation to other investigations 
As mentioned earlier, a significant number of immigrants to Abu Dhabi fall in the age range of 
20-40 years old are employed in the construction fields. Our study, however, did not show 
significant association with the diagnosis of MTB in relation to factors such as gender or 
nationality and application categories (group A: (white collars and construction), group Bi: 
(maids and drivers) and group Bii: (food handlers and hygienic staff)).  Similarly, our study 
found that visa type of residency application (whether applying for a new visa or a renewal) did 
not show a significant association with the diagnosis of MTB. 
The findings in our study were consistent with the data from the WHO where two-thirds of MTB 
cases were among males and the majority of cases came from countries of the South East Asia 
region. In addition, almost half of MTB cases occurred among applicants working in 
construction and were employed as workers, laborers or cleaners and helpers. When the 
applicant category grouping was used instead of occupation we noticed that more than 80% of 
MTB cases occurred in group A: (white collar and construction).  
A nested case-control study conducted on a cohort of migrants with an increased risk of 
tuberculosis in Australia between 1984 and 2003 reported a higher percentage of TB cases (57%) 
among younger migrants (<25-44) years-old compared to (37%) TB cases identified among older 
migrants (45-64) years-old.
33
 Similarly, in our study, more than 50% of immigrants fall into the 




the mean age among MTB cases is 33.2 (SD ±9.9) years. Therefore, more attention shall be 
directed towards finding the best screening algorithm to accelerate case detection and possible 
dormant infection among residency applicants eligible for chemoprophylactic therapy in the 
younger visa applicants. 
A study In Japan enrolled bacteriologically confirmed active TB patients and healthy volunteers 
assumed to be uninfected with Mycobacterium tuberculosis as controls. The study evaluated the 
diagnostic performance of QFT-Plus in comparison to that of QuantiFERON-TB Gold In-Tube 
(QFT-GIT) and the sensitivity in the TB patients and specificity in the healthy volunteers were 
obtained.
58 
The study found that IFN-γ values were significantly reduced with age in QFT-GIT 
(P = 0.035).
58
 Similarly, in Poland, a study was conducted to assess the validity of IGRA and 
TST among culture negative and culture positive TB patients; they reported that ―IGRA 
sensitivity was age-dependent and a higher sensitivity of the test was observed among younger 
patients than those aged older than 60 years‖.
40
 In our study, among the younger age group 
IGRA (QFT-GIT) sensitivity was 78.1%, (95% CI: 72.3- 83.3). IGRA (QFT-GIT) sensitivity 
was better than TST sensitivity and was even better than IGRA (QFT-GIT) sensitivity in the 
older age group in the study.  
 
The debate as to which indirect tests for TB are optimal in screening programs continues, in part 
due to inconsistent results of sensitivity tests for IGRA and TST across tests and populations.
35
 
In low-incidence TB settings, the use of IGRAs is increasingly recommended yet there is no 
consistency in the recommendations on how to use it.
35




incidence and low-resource countries since there is no strong evidence that IGRAs are superior 
to the TST in such settings, particularly when taking into consideration the significantly higher 
costs associated with the IGRA.
35
  
In addition, there was no reliable evidence that IGRA was more sensitive than the TST for the 
diagnosis of active tuberculosis.
37
 In a meta-analysis of studies in low-income and middle-
income countries assessing the use of IGRAs for active TB, the pooled sensitivity in HIV-
infected patients was 60% for the QFT-GIT compared with 69% for QFT-GIT in non-HIV-
infected patients.
37
 The specificity of IGRA was low for non-HIV-infected individuals (QFT-
GIT 52%) as well as for HIV-infected individuals (QFT-GIT 50%).
35, 37 
 
Those results were further confirmed by another meta-analysis assessing studies from both high-
incidence and low-incidence countries, including children and HIV-infected individuals 
especially the low specificity in individuals with suspected TB.
59
 In brief, both systematic 
reviews concluded that IGRAs should not be used in the diagnostic investigations of active TB in 
adults since ―a positive IGRA result may not indicate active TB and similarly, a negative IGRA 
result may not rule out active disease‖.
59
 A good number of guidelines reveal these limitations of 
IGRAs in respect to the diagnosis of active TB (Table 5.3).
35
 When IGRAs are recommended for 
the diagnosis of active TB, they are obviously considered only as an adjunct test in addition to, 







Sester et al. compared TST and IGRA in individuals using active TB infection as a substitute for 
LTBI.
15, 59
 They concluded that IGRAs are more sensitive than TST and that IGRAs have limited 
accuracy in diagnosing active TB.
59
 It is important therefore to present such evidence in 
guidance documents to ascertain that the assays are only applied in diagnostic algorithms where 
they are of established accuracy.
59
 According to the Sester et al. systematic review, the 
sensitivity of IGRAs performed on blood is superior to that of TST in patients with active TB, 
yet the low specificity may indicate a limited value of IGRAs to differentiate between 




Imaging has a significant role in the diagnosis and treatment options of active tuberculosis.
34
 
Radiographic screening serves a primary purpose for tuberculosis as it guides the detection of 
possible cases of the active pulmonary disease in need for further evaluation and management.
34
 





The presence of cavitations in imaging, for example, will influence treatment decisions such as 
the length of a course of therapy required to cure an individual of the active disease.
34
  
In addition, imaging has a crucial role in risk stratification as it provides a guide to distinguish 
between latent infection, previous inactive disease, and active disease.
34
 The presence of unique 
fibro-nodular lesions in upper zones of the lung and the presence of parenchymal infiltrates are 
both associated with subsequent active TB.
33
 A significant predictor for TB in imaging is linked 
to the size of the lesion area.
33
 Larger lesion areas in imaging are associated with an increased 
risk of TB compared with individuals with a normal chest X-ray or those with small lesions.
33
 In 
the literature, minor findings consistent with past primary infection do not indicate an increased 
risk of consequent tuberculosis and shall not be used for further surveillance.
33
 This was 
demonstrated in our study results as more than two-thirds of confirmed MTB cases occurred 
among those with a chest X-ray evaluation of Suspicion of TB. In addition, our study found that 
applicants with a chest X-ray evaluation of abnormal Not/Old TB group had a lower probability 
of MTB compared to those with a chest X-ray evaluation of Suspicion of TB. A new radiological 
scoring system for the visa screening standards in Abu Dhabi is needed to enhance the sensitivity 
of chest X-ray evaluation of tuberculosis by radiologists. The provision of unique training 
workshops to help establish the basis of a solid and unified reporting system among radiologists 
is also required. 
 
Study limitations 
In our study, several limitations need to be addressed. First, the limited budget influenced the 




threat to the external validity of the study given that the participants are self-selected, the results 
cannot be generalized to those who decided not to participate (e.g., by not applying for a 
residency visa in Abu Dhabi) or to other similar geographical areas. Sample size and the absence 
of a true control group were other threats to the external validity of the study. Second, 
information about smoking history, co-morbidities such as diabetes and cancer, alcohol intake 
and IGRA (QFT-GIT) quantitative measurements were not available. Analysis including the 
previously mentioned risk factors would add to the richness of the study and would provide more 
information to be utilized in TB/LTBI screening and to be better management plans. Third, the 
merging between individuals with Abnormal Not TB chest X-ray evaluation and abnormal old 
TB chest X-ray evaluation in one group due to limited numbers is another limitation in the study. 
Future studies to explore each category separately are therefore needed. Finally, secondary 
analysis of the 281 cases with MOTT was not feasible and the inclusion of those cases is, 
therefore, advised in future studies for comparison purposes. 
Conclusions 
The United Arab Emirates is recognized for its highly varied population and a very high gender 
imbalance. Moreover, it was ranked as the 7th highest net migration rate in the world, mostly 
originating from South Asian countries.  A higher percentage of younger individuals were 
applying for a new residency visa while older individuals were more predominantly seen in the 
renewal category. Similarly, a higher percentage of younger individuals were employed as 
servants and babysitters mainly from Ethiopia, Indonesia, and the Philippines.  
The sensitivity of IGRA (QFT-GIT) obtained in our study 72.7%, (95% CI: 67.8-77.2) is similar 




sensitive than TST. Though the NPV of IGRA (QFT-GIT) in our study is high, it is insufficient 
to ‗rule out‘ the disease as one in 10 non-MTB cases will be missed for MTB. The positive and 
negative likelihood ratios of both tests are small and did not add to the usefulness value for the 
diagnosis of active TB.  Both IGRA (QFT-GIT) and TST, therefore, have a limited utility in 
‗ruling out‘ or ‗ruling in‘ active TB. 
In our study, the sensitivity of simultaneous (parallel) tests using IGRA (QFT-GIT) and TST is 
88.8%. The sensitivity had even increased to 91.5% when the parallel test was applied to the 
younger individuals (18-34 years). However, Kappa agreement between IGRA (QFT-GIT) and 
TST was 0.33 and (95% CI: 0.29-0.36) which is considered as only fair concordance. False-
positive TST results due to BCG vaccination or non-tuberculous mycobacteria (NTM) exposure 
can explain the discordance of results (positive TST and negative IGRA (QFT-GIT)). In our 
study, the sensitivity and specificity of chest X-ray are 71% (95% CI: 67–76) and 55% (95% CI: 
53–57) respectively, lower than what was reported in the literature. Though the NPV of chest X-
ray in our study was high yet this is not enough to ‗rule out‘ the disease. Therefore, the 
establishment of a concise chest X-ray scoring system related to tuberculosis is needed to 
increase the sensitivity of the current radiological evaluations. 
In our study, two-thirds of MTB cases are males and the majority of cases are from countries of 
the South East Asia region. In addition, almost half of MTB cases occurred among applicants 
working in construction and were employed as workers, laborers or cleaners and helpers. Our 
study is a cross-sectional study with a statistical control group that explored several possible 




association of MTB with other risk factors such as smoking and diabetes in the same population. 
The significant association between younger age and MTB among the screened individuals, 
therefore, might be further explored by further future studies. This can be followed by cost-
effectiveness analysis of treating latent tuberculosis infection among screened individuals as a 





























Chapter 6 will provide a highlight of possible policy implications and recommendations in 4 
sections:  
Section (A): Awareness of Mycobacterium tuberculosis infection. This section will provide 
recommendations 1 and 2 to raise the awareness of the Mycobacterium tuberculosis infection 
among different target groups such as clinicians, visa applicants, sponsors and owners of 
companies in Abu Dhabi. 
Section (B): Smoking cessation clinics. This section will provide recommendation 3 to establish 
smoking cessation clinics. 
Section (C): Upgrading the current visa screening services. This section will provide 
recommendation 4, 5, and 6 to highlight the role of IGRA and TST simultaneous testing in LTBI 
screening among visa applicants. The screening for diabetes among adults applying for renewal 
residency visa will be addressed too. Finally, the importance of the healthy working environment 
for laborers, helpers and, workers will be emphasized. 
Section (D): Children at higher risk of MTB. This section provides recommendation 7, and 8 to 
highlight BCG vaccination among children under 5 years of age and early detection of LTBI 
among university students. 
Policy implications and recommendations 
Section (A): Awareness of Mycobacterium tuberculosis infection 
Recommendation 1:  Enhance the current awareness of Mycobacterium tuberculosis 
infection early diagnosis and management among clinicians and healthcare providers in 
public and private sectors and correctional residential institutes in Abu Dhabi 
Raising the awareness, among clinicians and healthcare providers in Abu Dhabi, regarding 
Mycobacterium tuberculosis infection risk can occur through focus groups and training 




tuberculosis infection at global and local levels. The correct perception of disease burden is 
intended to motivate clinicians during their practice to collaborate with the efforts of the WHO to 
reach the End of TB strategy goals. In addition, the training should highlight the benefits of early 
detection and management of the disease. The information provided through the training 
workshops such as the proper duration of treatment regimens or how to choose the proper 
screening test for LTBI will establish the self-confidence and the required abilities among 
clinicians to practice efficiently. This will eventually help clinicians to achieve and maintain the 
ultimate goal of preventing the development of new TB disease among high-risk groups. In 
addition, clinicians will be actively involved in the prevention of the development of multidrug 
resistance (MDR) due to non-compliance among those receiving the treatment for TB. Moreover, 
barriers to care provision can be overcome through continuous and transparent feedback, 
reassurance and support from the DOH/HAAD and the senior management in healthcare centers. 
Recommendation 2:  Enhance the current awareness of Mycobacterium tuberculosis 
infection early management and the importance of embracing a healthy lifestyle in the 
community  
The involvement of the visa applicants, the sponsors and the owners of companies is crucial at 
the initial stage to establish the understanding and the consensus on the importance of efforts 
aiming at minimizing the risk of Mycobacterium tuberculosis in the community. Therefore, the 
awareness of TB/LTBI needs to be emphasized initially among those stakeholders so that they 
can actively collaborate in passive tuberculosis case-finding and the initiation of early 




the passion towards embracing healthy lifestyles among members of the community.  Short 
video and internet messages, posters, illustrated awareness pamphlets and roll up banners in 
different languages (Arabic, English, and Hindi, Urdu, Bengali and Indonesian, Nepali and 
Amharic) can all be utilized for this purpose. Media would play a vital role in the modification of 
some of the predisposing behavioral factors in the community to support and motivate embracing 
healthy lifestyle changes among specific groups (such as young adults, those with diabetes, 
smokers, and alcohol consumers).  
 
Section (B): Smoking cessation clinics  
Recommendation 3:  Establishment of smoking cessation clinic targeting clients in the 
Disease Control section and occupational clinics  
The number of TB cases is expected to inflate in the future as a result of the growing population 
particularly in countries like India and China.
42
 Moreover, the risk of progression to TB disease 
in these endemic countries will also increase as a result of high smoking rates along with rising 
rates of diabetes.
42
 Therefore, it is advocated to consider interventions such as smoking cessation 
and early screening for TB in such situations.
42
  
In Abu Dhabi, collaborative efforts are needed to in order to face the challenge of smoking 
among different community members. Policy makers and the DOH/HAAD can support the 
establishment of smoking cessation clinics in the government sector under mandated insurance 
programs.  The provision of smoking cessation services linked to the visa screening process and 
to occupational clinics need to be integrated with efforts targeting early detection of TB/LTBI 




preventive program is needed to boost the effectiveness of the smoking cessation services and 
TB/LTBI management efforts in the community.  The current anti-smoking media messages 
need to be revised to assess for defects and the future messages need to be designed cautiously 
for the intended audience. The material about smoking dangers in the current visa screening 
centers, occupational clinics, and private sector shall be assessed as well. Regular measurement 
and assessment of major outcomes in the smoking cessation clinic along with TB/LTBI 
successful treatment completion rates are also needed to monitor the progress of the proposed 
interventions. 
Section (C): Upgrading the current visa screening in Abu Dhabi 
Recommendation 4:  Upgrading the current visa screening process to detect LTBI among 
high-risk groups  
In high-incidence settings, TB is frequently the result of a new acquisition of Mycobacterium 
tuberculosis while in low-incidence countries a large proportion of TB disease is the result of 
reactivation of latent TB.
35
 Therefore, in low-incidence countries, the detection and management 
of LTBI is a key component of TB control.
35
 The attention should be directed towards treating 
latent infection in those individuals who present in the migration setting if not provided earlier in 
their home countries. Detecting and treating LTBI among individuals applying for residency is a 
priority in low-incidence countries such UAE. The integration of LTBI screening with the 
current active TB screening is therefore required. The visa screening program in the Emirate of 
Abu Dhabi will be most productive and efficient by the integration of LTBI screening mainly 




Although it is costly to add the IGRA (QFT-GIT) to a screening program, it has an added value 
and can be requested for young immigrants applying for residency.
15
 The integration of IGRA 
(QFT-GIT) test along with chest X-ray and sputum culture test for the screening of young 
individuals applying for residency might be a suggested step towards minimizing the risk of 
missed LTBI cases. The implementation of IGRA (QFT-GIT) test can aid in the detection of 
cases eligible for LTBI chemoprophylactic treatment. Moreover, immigrants coming from high-
incidence countries may be the contact of active TB cases prior to arriving into low-incidence 
counties. The available studies on cost-effectiveness are supportive of the use of IGRAs in 
screening high-risk groups, such as healthcare workers, immigrants from high-incidence 
countries, and close contacts.
38 
Therefore; adding IGRA (QFT-GIT) test will help in reduction of 
the number of unnecessary prophylactic treatment. This was evident from a recent study reported 
that the addition of IGRA (QFT-GIT) in BCG-vaccinated TB contacts had safely reduced TB 
diagnosis and treatment rates without increasing the risk of subsequent active TB.
55
 The 
prophylactic treatment of LTBI can be offered then to younger individuals with positive IGRA 
(QFT-GIT) test after the exclusion of active disease (by negative sputum culture test) and or old 
TB infection in the Disease Control section in DPSCs as a step towards minimizing the risk of 
developing active TB among individuals applying for residency in the Emirate of Abu Dhabi.  
 
Recommendation 5:  Upgrading the current visa screening process to detect diabetes 
among residents applying for renewal visas  
Shah et al. reported a high level of overweight and obesity among migrant women after 10 years 
of residency in the UAE.
53




times the prevalence of type 2 diabetes mellitus compared to the more recent arrivals.
53
 The 
association between diabetes and TB was examined in a systematic review comparing 13 studies 
and it was concluded that patients with diabetes had a threefold higher risk of developing TB 
when compared to those without the disease.
42
 Adding diabetes screening test for adults applying 
for renewal residency will be a new step that will empower the strategic efforts of the public 
health sector in Abu Dhabi. Individuals diagnosed with diabetes during the visa renewal 
screening can befit from the IGRA (QFT-GIT) test for LTBI diagnosis as well prior to referral to 
either chronic disease clinics in the primary care sectors or occupational health clinics for further 
management. 
 
Recommendation 6:  Encourage healthy working environments for immigrants in Abu 
Dhabi  
Al-Maskari et al. reported that the majority of South Asian immigrants who are unskilled males 
with low educational levels, employed in low salary jobs, and living in large labor camps, suffer 
from stress, anxiety, and depression.
60, 61
 In addition, Shah et al. found a relatively high 
prevalence of hypertension in a representative sample of young male South Asian immigrants 
living in the UAE.
61
 Sadly, within this population, the awareness of hypertension, treatment, and 
control of disease was very low.
61
  
Awareness among important stakeholders in large companies and governmental institutes in Abu 
Dhabi should be raised to improve the current working environments for those laborers. The 
implantation of the recognition strategies directed towards this category such as best 




performers in the magazine of the organization is advised. Recognition of laborers and helpers 
for good work by simple certificates and simple awards from time to time in a social gathering 
towards the end of a working day or during an evening outside work hours if feasible would 
recover the spirit of hard workers and would be a good initial step towards alleviating the 
hardship they are facing. Employers in this category should be encouraged and supported to seek 
proper medical attention especially if diagnosed with chronic diseases such as hypertension and 
diabetes.   
 
The DPSCs provide a good example of a friendly working environment as the cleaners and 
helpers are well recognized, respected and supported by the higher management and the rest of 
employees.  The passion of those workers towards the organization and the staff was the product 
of being treated and valued as important members of the community. Therefore, the current 
scattered and successful efforts noticed in some governmental entities in Abu Dhabi need to be 
merged into a policy that supports and guide the efforts of providing a healthy working 
environment.  
 
Section (D): Children at higher risk of MTB 
Recommendation 7:  Mandate the provision of BCG vaccination records for the 
dependents’ children below 5 years old  
The highest risk for TB-related mortality occurred as a result of primary TB infection during 
infancy period.
42
 The risk of TB-related mortality declined to 1% between 1 and 4 years of age, 
and then it escalates to more than 2% from 15 to 25 years of age.
42




evidence of BCG vaccination need to be mandated as part of visa application process for 
individuals accompanied by their dependents below 18 years of age. If not possible, then an 
urgent appointment with pediatrician needs to be arranged soon after arrival in Abu Dhabi for 
assessment and opinion regarding BCG vaccination. The status of TB/LTBI in children, below 
18 years-old, coming from high-incidence regions is not known. Furthermore, the possible 
exposure of Emirati children to infected maids, babysitters and drivers during their childhood 
cannot be ignored. Thus, the establishment of a well-organized and integrated pediatric contact 
tracing program in Abu Dhabi is advocated mainly among high-risk groups such as infants 
exposed recently to highly contagious TB cases.  
 
Recommendation 8:  Consider LTBI screening and prophylactic treatment among 
students applying for university   
Screening for LTBI and the provision of prophylactic treatment might be considered as part of 
university requirements for admission for students, especially those who are going to stay in a 
university dormitory. In Abu Dhabi, visa screening starts at age of 18 years and the status of 
TB/LTBI among those young adults coming from high-incidence regions is not known. In 
addition, the LTBI status among local students in the UAE and in Abu Dhabi, in particular, need 
to be assessed given that IGRA test was positive in 8% Emirati medical students (preclinical and 
clinical) in a prospective cohort study between July 2011 and May 2012.
64
 The earlier study 
recommended the inclusion of IGRA test in admission screening, particularly in areas where 
BCG vaccination is universal.
64
 Therefore, the current public health efforts in Abu Dhabi need to 





Mycobacterium tuberculosis infection continues to be a global public health challenge requiring 
multiple levels of consistent efforts from local and international healthcare systems. In Abu 
Dhabi, efforts to raise the awareness of Mycobacterium tuberculosis infection are needed among 
different community members including clinicians, visa applicants and owners of companies. 
The establishment and the incorporation of smoking cessation services in visa screening and 
occupational health clinics is a promising step requiring the support from policy-makers in Abu 
Dhabi.  Upgrading the current visa screening services in Abu Dhabi to include the screening for 
LTBI among high-risk categories and the screening for diabetes among those applying for 
renewal residency are advocated. Additional collaboration to help guide the scattered efforts 
intended to create steady and healthy working environments for workers, helper, and labors 
serving in UAE and in Abu Dhabi, in particular, is highly emphasized. For children below 5 
years-old accompanying their parents, the provision of BCG vaccination records need to be 
mandated as part of residency requirements. The arrangement for pediatric assessment soon after 
arrival into Abu Dhabi for those lacking the records for BCG counseling is advocated.  In 
addition, the establishment of a well-organized and integrated pediatric contact tracing program 
in Abu Dhabi needs the attention of the policymakers. Finally, screening for LTBI and the 
provision of prophylactic treatment might be incorporated as part of university requirements for 
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